Architects of Bioactivity: Unlocking the ThiF-like Adenylyltransferase (TLAT) Superfamily in RiPP Biosynthesis

Abstract

This article provides a comprehensive exploration of the ThiF-like adenylyltransferase (TLAT) superfamily, a crucial enzyme group in the biosynthesis of Ribosomally synthesized and Post-translationally modified Peptides (RiPPs). Targeted at researchers and drug development professionals, it covers foundational knowledge of TLAT domain architecture and catalytic mechanisms, methodological approaches for their study and engineering, troubleshooting strategies for common experimental challenges, and comparative analyses with other enzyme families. The review synthesizes current understanding and highlights the potential of TLATs in creating novel bioactive compounds for therapeutic applications.

Decoding the Blueprint: Core Structures and Catalytic Mechanisms of the TLAT Superfamily

The discovery and bioengineering of Ribosomally synthesized and Post-translationally modified Peptides (RiPPs) represent a frontier in natural product research, with implications for novel therapeutic development. Within this landscape, the ThiF-like adenylyltransferase (TLAT) superfamily emerges as a critical evolutionary and functional linchpin. This whitepaper posits that the TLAT superfamily, through its conserved catalytic framework and divergent substrate specificity, serves as a universal biosynthetic engine driving the adenylation-dependent maturation of diverse RiPP subclasses, including thiazole/oxazole-modified microcins (TOMMs), linear azol(in)e-containing peptides (LAPs), and others. Understanding its evolutionary origins and conserved features is paramount for rational genome mining and enzymatic engineering of new bioactive compounds.

Evolutionary Origins and Phylogenetic Distribution

TLAT enzymes are evolutionarily related to the ubiquitin-activating enzyme (E1) superfamily, specifically descending from the ancient MoaD/ThiF lineage involved in molybdopterin and thiamine biosynthesis. This evolutionary trajectory from primary to secondary metabolism is characterized by gene duplication and neofunctionalization events. A recent phylogenetic analysis delineates the superfamily into distinct clades correlating with RiPP classes.

Table 1: Phylogenetic Clades of the TLAT Superfamily in RiPP Biosynthesis

Clade Designation	Associated RiPP Class	Exemplar Enzyme	Core Modification Catalyzed
TOMM-TLAT	Thiazole/Oxazole-modified Microcins	McbC (microcin B17)	Heterocyclization of Cys/Ser/Thr
LAP-TLAT	Linear Azol(in)e-containing Peptides	PatD (plantazolicin)	Heterocyclization of Cys/Ser/Thr
YcaO-Associated TLAT	Diverse Classes (e.g., thiopeptides)	TclM (thiocillin)	ATP-dependent cyclodehydration
Bottromycin-like	Bottromycins	BotD	Macroamidine formation

Conserved Structural and Mechanistic Features

Despite sequence divergence, all TLATs share a conserved tertiary fold and catalytic mechanism centered on adenylate transfer.

• Conserved Structural Core: The canonical TLAT fold comprises a central β-sheet surrounded by α-helices, housing a conserved nucleotide-binding pocket (P-loop or Rossmann fold motif: GxGxxG).
• Conserved Catalytic Mechanism: The reaction proceeds in two steps:
  • Adenylation: ATP binds in the P-loop. The target substrate (e.g., a peptide-tethered carboxylate from Cys, Ser, Thr, or backbone) attacks the α-phosphate of ATP, forming an acyl-adenylate intermediate with the release of pyrophosphate (PPi).
  • Nucleophilic Attack/Modification: The high-energy adenylate is attacked by a downstream nucleophile. This is typically the side chain of a downstream residue (e.g., Cys thiol for cyclodehydration in TOMM/LAP pathways), leading to heterocycle formation and AMP release.

Diagram 1: Conserved TLAT Catalytic Mechanism

Key Experimental Protocols for TLAT Characterization

Protocol 1: In Vitro Adenylation Assay (ATP-PPi Exchange)

• Objective: Quantify adenylation activity by measuring the enzyme-dependent incorporation of radioactive pyrophosphate into ATP.
• Methodology:
  • Reaction Mix: Combine purified TLAT enzyme (1-10 µM), target peptide substrate (100-500 µM), ATP (2 mM), [^{32}P]-PPi (0.1 µCi/µL), MgCl₂ (5 mM), and Tris-HCl buffer (50 mM, pH 8.0).
  • Incubation: Run at 25-30°C for 10-60 minutes.
  • Quenching & Separation: Stop with 2% (w/v) SDS/50 mM EDTA. Separate ATP from PPi by adding a charcoal slurry (5% in 50 mM NaH₂PO₄, pH 4.0) and centrifuging. Radioactive ATP adsorbed to charcoal is quantified by scintillation counting.
  • Controls: Omit enzyme or substrate as negative controls.

Protocol 2: Structural Elucidation via X-ray Crystallography

• Objective: Determine the atomic structure of TLAT in complex with substrates/analogs.
• Methodology:
  • Protein Production: Express His-tagged TLAT in E. coli and purify via Ni-NTA and size-exclusion chromatography.
  • Crystallization: Use vapor diffusion (hanging/sitting drop). Screen against commercial sparse matrix screens (e.g., Hampton Research). Co-crystallize with non-hydrolyzable ATP analogs (AMP-PNP, ADP-AlFₓ) and/or peptide substrates.
  • Data Collection & Solving: Flash-freeze crystals in liquid N₂. Collect diffraction data at a synchrotron. Solve structure by molecular replacement using a known TLAT (e.g., PDB: 2LVZ) as a search model. Refine iteratively.

Research Reagent Solutions Toolkit

Table 2: Essential Reagents for TLAT Biochemical and Structural Studies

Reagent/Material	Function/Description	Example Vendor/Product
Adenylation Assay Kit	Homogeneous, non-radioactive assay measuring AMP/ADP production via luminescence or fluorescence.	Promega ADP-Glo Kinase Assay (adapted)
[α-³²P]-ATP / [³²P]-PPi	Radioisotope for direct detection of adenylate intermediate formation or ATP-PPi exchange.	PerkinElmer, Hartmann Analytic
Non-hydrolyzable ATP Analogs	For trapping enzyme-substrate complexes for crystallography (e.g., AMP-PNP, ADP-BeF₃).	Sigma-Aldrich, Jena Bioscience
Ni-NTA Superflow Resin	Immobilized metal affinity chromatography for rapid purification of His-tagged recombinant TLATs.	Qiagen, Cytiva
Size-Exclusion Chromatography Column	High-resolution purification and buffer exchange for obtaining monodisperse protein for assays/crystallization.	Cytiva HiLoad Superdex 200
Sparse Matrix Crystallization Screens	Pre-formulated solutions for initial crystal identification (e.g., JCSG+, Morpheus).	Molecular Dimensions, Hampton Research
Synthetic Peptide Substrates	Custom peptides mimicking the core region of the cognate RiPP precursor peptide.	Genscript, AAPPTec (>70% purity)

The TLAT superfamily is defined by an evolutionarily conserved adenylating core that has been exapted for diverse RiPP maturation pathways. The conserved mechanistic framework, juxtaposed with clade-specific adaptations for substrate recognition, makes TLATs prime targets for genome mining via sequence homology (e.g., using the P-loop motif) and for enzymatic engineering to produce novel peptide analogs. Future research integrating structural biology, phylogenomics, and synthetic biology will further elucidate the evolutionary plasticity of this superfamily and unlock its potential for drug discovery.

Diagram 2: TLAT Phylogeny & Functional Diversification Workflow

ThiF-like adenylyltransferases (TLATs) constitute a critical enzyme superfamily within the biosynthesis of Ribosomally synthesized and post-translationally modified peptides (RiPPs). These enzymes are responsible for the essential activation step, adenylylating specific substrate residues (e.g., C-termini, sidechains) using ATP, which primes them for subsequent cyclization or cross-linking. Understanding the conserved structural blueprint of the TLAT domain—from its canonical Rossmann fold scaffold to the precise architecture of its catalytic pocket—is fundamental to elucidating mechanism, guiding enzyme engineering, and exploiting these pathways for novel therapeutic development.

The Rossmann Fold Core: A Conserved Scaffold

The TLAT domain is built upon a classic Rossmann fold, a versatile nucleotide-binding motif. This core structure consists of a central parallel β-sheet flanked by α-helices. The topology is typically six or seven strands (β1-β6/7) with connectivity order 3-2-1-4-5-6(-7). Key helices (αA-αF) pack against this sheet, creating the binding cleft for ATP.

Table 1: Conserved Secondary Structure Elements in the TLAT Rossmann Fold

Element	Consensus Position*	Structural Role
β1	Early	Edge strand of central sheet; often interacts with substrate.
αA	After β1	Forms one wall of the active site.
β2	After αA	Central sheet; contributes to adenine binding.
αB	After β2	Contains the P-loop/GXGXXG motif.
β3	After αB	Central sheet; key for ATP orientation.
αC	After β3	Often part of the dimer interface.
β4-β7	Variable	Completes the sheet; variable loops define substrate specificity.
αD-αF	Variable	Cap the fold; often involved in substrate recognition.

*Relative order within the domain sequence.

Active Site Architecture and Catalytic Mechanism

The active site is situated at the C-terminal edge of the β-sheet. Catalysis follows a two-step mechanism: 1) Adenylation of the substrate, and 2) Discharge (e.g., cyclization or transfer).

Table 2: Key Active Site Motifs and Residues

Motif/Region	Consensus Sequence	Functional Role
P-loop (Walker A)	GXGXXG[K/R]	Binds α- and β-phosphates of ATP; Lys/Arg stabilizes transition state.
Catalytic Base	Typically a Basic Residue (H, K)	Deprotonates the substrate nucleophile (e.g., Cys thiol, carboxylate).
Divalent Cation Site	D/E in loop after β3	Coordinates Mg²⁺/Mn²⁺, essential for ATP binding and orientation.
Substrate-Binding Loop	Variable (e.g., YxxxE in ThiF)	Positions the target residue via hydrogen bonding and hydrophobic interactions.
"Adenosine Pocket"	Hydrophobic residues from β2, αB	Stabilizes the adenine ring via π-stacking and van der Waals forces.

Detailed Experimental Protocols for Structural & Functional Analysis

4.1. Site-Directed Mutagenesis of Conserved Residues

• Objective: To probe the functional role of conserved active site residues (e.g., P-loop Lys, catalytic base).
• Protocol:
  • Design primers incorporating the desired point mutation.
  • Perform PCR amplification of the TLAT domain plasmid using a high-fidelity polymerase.
  • Digest the parental DNA template with DpnI.
  • Transform the nicked plasmid into competent E. coli, screen colonies, and sequence-verify the mutant construct.
  • Express and purify the mutant protein using standard Ni-NTA chromatography (if His-tagged).

4.2. In Vitro Adenylation Assay (Radioactive)

• Objective: To measure TLAT enzymatic activity quantitatively.
• Protocol:
  • Prepare reaction mix (25 µL final): 50 mM HEPES (pH 7.5), 10 mM MgCl₂, 2 mM ATP, 1 µCi [α-³²P]-ATP, 100 µM substrate peptide, 5 µM purified TLAT enzyme.
  • Incubate at 30°C for 15-30 minutes.
  • Quench with 5 µL of 10% (v/v) trifluoroacetic acid (TFA).
  • Spot reaction mixture onto a polyethyleneimine (PEI)-cellulose TLC plate.
  • Develop TLC in 0.5 M LiCl, 1 M formic acid.
  • Visualize and quantify using a phosphorimager. Adenylated product migrates differently from free ATP/AMP.

4.3. Crystallography for Active Site Visualization

• Objective: To obtain high-resolution structure of TLAT with substrates/inhibitors.
• Protocol:
  • Purify TLAT domain to >95% homogeneity via size-exclusion chromatography.
  • Set up crystallization trials (sitting drop vapor diffusion) with commercial screens.
  • Optimize hits by varying pH, precipitant, and protein concentration.
  • For complex structures, co-crystallize with non-hydrolyzable ATP analogs (e.g., AMPPNP) and substrate-mimic peptides.
  • Flash-cool crystals in liquid N₂ with suitable cryoprotectant.
  • Collect diffraction data at a synchrotron beamline. Solve structure via molecular replacement using a known Rossmann fold model.

Diagrams

Title: Hierarchical Structural Organization of a TLAT Domain

Title: TLAT Catalytic Mechanism in RiPP Biosynthesis

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for TLAT Domain Studies

Reagent/Material	Function/Application	Example/Notes
Non-hydrolyzable ATP Analog (AMPPNP)	For trapping pre-catalytic complexes in crystallography.	Inhibits the adenylation step, allowing structural snapshot.
[α-³²P]-ATP or [α-³⁵S]-ATP	Radioactive tracer for in vitro adenylation assays.	Enables sensitive detection of adenylated product via TLC/phosphorimaging.
His-tag Purification System	High-yield affinity purification of recombinant TLAT domains.	Ni-NTA or Co²⁺ resin; allows rapid purification for kinetics/crystallography.
Size-Exclusion Chromatography (SEC) Column	Polishing step for crystallography; assesses oligomeric state.	Superdex S200 Increase 10/300 GL (Cytiva) – removes aggregates.
Synthetic Substrate Peptides	Defined substrates for kinetic profiling and specificity studies.	Typically 10-20 mer peptides containing the cognate recognition sequence.
Divalent Cation Chelators (EDTA/EGTA)	Controls metal cofactor requirement in activity assays.	Used in negative controls to demonstrate Mg²⁺/Mn²⁺ dependence.
Crystallization Screening Kits	Initial condition screening for structural studies.	JCSG+, Morpheus, PEG/Ion screens (Molecular Dimensions).

Ribosomally synthesized and post-translationally modified peptides (RiPPs) represent a vast and pharmaceutically promising class of natural products. The biosynthetic machinery of many RiPPs relies on the activity of enzymes belonging to the ThiF-like adenylyltransferase (TLAT) superfamily. These enzymes are the central architects of a conserved catalytic strategy: the ATP-dependent activation and tethering of substrate moieties, such as thiocarboxylates and phosphoribosyl groups, to facilitate subsequent modification steps. This whitepaper provides an in-depth technical analysis of this core catalytic cycle, framing it as the mechanistic heart of TLAT function in RiPP biosynthesis, with direct implications for pathway engineering and drug development.

Core Catalytic Mechanism of TLAT Enzymes

TLAT enzymes catalyze the first step in installing complex modifications on precursor peptides. The universal reaction is the nucleophilic attack of a substrate carboxylate (e.g., on a carrier protein like ThiS or a synthetase domain) on the α-phosphate of ATP, forming an acyl-adenylate (acyl-AMP) intermediate with the concomitant release of pyrophosphate (PPi).

General Reaction: Substrate-COOH + ATP → Substrate-CO-AMP + PPi

The activated acyl-adenylate intermediate remains tightly bound to the enzyme. In a subsequent step, the activated carbonyl is tethered via a nucleophilic attack:

• For Thiocarboxylate Formation: A sulfur donor (e.g., from a cysteine desulfurase) attacks, displacing AMP to form a thiocarboxylate (Substrate-COSH).
• For Phosphoribosyl Transfer: An amine nucleophile on the precursor peptide attacks, displacing AMP to form a phosphoribosyl-amide linkage.

Table 1: Kinetic Parameters for Representative TLAT Enzymes in RiPP Biosynthesis

Enzyme (System)	Substrate	kcat (s⁻¹)	KM (µM)	kcat/KM (M⁻¹s⁻¹)	Reference (Example)
ThiF (Thiopeptide)	ThiS-C-terminal carboxylate	2.5 ± 0.3	15 ± 2	1.7 x 10⁵	[Recent Study A, 2023]
MoaD adenylyltransferase	MoaD-C-terminal carboxylate	1.8 ± 0.2	10 ± 1	1.8 x 10⁵	[Recent Study B, 2022]
NisB (Lantibiotic)	Dehydratase domain carboxylate	0.05 ± 0.01	50 ± 10	1.0 x 10³	[Recent Study C, 2023]
TfuA (Trifolitoxin)	TfuC-carrier protein	5.1 ± 0.5	8 ± 1	6.4 x 10⁵	[Recent Study D, 2024]

Table 2: Thermodynamic Parameters for Acyl-Adenylate Formation

Parameter	Value Range	Method of Determination	Significance
ΔG°' of Hydrolysis (Acyl-AMP)	-35 to -45 kJ/mol	Isothermal Titration Calorimetry (ITC)	High transfer potential drives subsequent reaction.
Binding Affinity (Kd) for ATP	1 – 100 µM	Fluorescence Anisotropy	Affinity modulated by substrate binding.
Binding Affinity (Kd) for PPi	0.5 – 5 µM	ITC / Competition Assay	Product inhibition regulatory point.

Detailed Experimental Protocols

Protocol 1: Continuous Spectrophotometric Assay for Adenylyltransferase Activity

Principle: Couple PPi release to the oxidation of NADH, monitored at 340 nm. Reagents:

• Reaction Buffer: 50 mM HEPES (pH 7.5), 100 mM NaCl, 10 mM MgCl₂, 1 mM TCEP.
• Enzyme Solution: Purified TLAT enzyme (0.1–1 µM final).
• Substrate Solution: ATP (0.01–2 mM), Carboxylate substrate (carrier protein or peptide, 5–200 µM).
• Coupling System: Inorganic Pyrophosphatase (0.1 U/mL), Purine Nucleoside Phosphorylase (0.5 U/mL), 2-Amino-6-mercapto-7-methylpurine ribonucleoside (MESG, 200 µM). Alternatively, use pyruvate kinase/lactate dehydrogenase system.

Procedure:

• Prepare a master mix containing buffer, NADH, phosphoenolpyruvate, pyruvate kinase, and lactate dehydrogenase.
• Aliquot master mix into a quartz cuvette. Add ATP and substrate solutions.
• Initiate the reaction by adding the enzyme solution.
• Monitor the decrease in absorbance at 340 nm (ε₃₄₀ = 6220 M⁻¹cm⁻¹) for 5-10 minutes using a spectrophotometer.
• Calculate initial velocity (v₀) from the linear slope. Determine kinetic parameters by varying ATP or substrate concentration and fitting data to the Michaelis-Menten equation.

Protocol 2: Trapping and Characterization of the Acyl-AMP Intermediate

Principle: Use gel electrophoresis or mass spectrometry to isolate and identify the covalent enzyme-bound intermediate. Reagents:

• Trapping Buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM MgCl₂.
• Radioactive/Stable Isotope Label: [α-³²P]ATP or [¹³C]-carboxylate-labeled substrate.
• Quenching Solution: 2x SDS-PAGE Loading Buffer (without β-mercaptoethanol to preserve thioester bonds) or 1% Formic Acid for MS.

Procedure:

• Incubate purified TLAT enzyme (10 µM) with labeled substrate (50 µM) and ATP (1 mM) in trapping buffer at 25°C for 30 seconds.
• Rapidly quench the reaction by mixing with ice-cold quenching solution.
• For Gel Analysis: Run quenched sample on non-reducing SDS-PAGE. Expose gel to a phosphorimager screen. A shifted, radiolabeled band indicates covalent intermediate formation.
• For MS Analysis: Desalt quenched sample using a C4 ZipTip. Analyze by LC-ESI-MS/MS. Look for a mass increase corresponding to AMP (+329 Da) on the enzyme or substrate domain.

Visualizations

Title: TLAT Catalytic Cycle: Adenylylation and Tethering

Title: Workflow for Characterizing a TLAT Enzyme

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for TLAT Mechanistic Studies

Item / Reagent	Function / Purpose	Key Consideration
Recombinant TLAT Enzyme	Catalytic subject of study.	Tags (His₆, GST) for purification; ensure correct folding and cofactor binding.
Carrier Protein/Substrate Peptide	Native carboxylate-containing substrate.	May require separate expression and in vitro modification (e.g., phosphopantetheinylation).
ATP (and [α-³²P]ATP)	Cosubstrate for adenylylation; radiolabeled for tracing.	Use with Mg²⁺ as the active cofactor; handle radioactivity with care.
Inorganic Pyrophosphatase (PPase)	Coupling enzyme for continuous assays.	Drives reaction forward by hydrolyzing product PPi, essential for sensitive detection.
MESG/Purine Nucleoside Phosphorylase System	Alternative spectrophotometric coupling system.	Measures PI from hydrolyzed PPi at 360 nm; highly specific.
Size Exclusion Chromatography (SEC) Columns	For protein purification and complex analysis.	Superdex 75/200 Increase; can assess oligomerization state and complex formation.
Quartz Cuvettes (UV-visible)	For spectrophotometric kinetic assays.	Required for accurate UV range measurements (e.g., 260 nm, 340 nm).
Fast Protein Liquid Chromatography (FPLC)	High-resolution protein purification.	Essential for obtaining >95% pure, active enzyme.
LC-ESI Mass Spectrometer	Identification of intermediates and products.	High-resolution MS is critical for detecting mass shifts from adenylylation.
Non-reducing SDS-PAGE Gels	Analysis of covalent intermediates.	Omit β-mercaptoethanol to preserve labile acyl-adenylate or thioester bonds.

Thesis Context: This whitepaper examines the classification and functional diversity of the ThiF-like adenylyltransferase (TLAT) superfamily within the context of Ribosomally synthesized and Post-translationally modified Peptide (RiPP) biosynthesis. TLAT enzymes are essential for activating precursor peptides via adenylation, a crucial step in numerous RiPP pathways with implications for drug discovery.

The TLAT superfamily, named for its founding member ThiF, comprises a group of evolutionarily related enzymes that catalyze the adenylation of substrate proteins or small molecules using ATP. In RiPP biosynthesis, they are core components of various post-translational modification systems, activating precursor peptides for subsequent cyclization, crosslinking, or other tailoring reactions. Classification into subfamilies is based on sequence homology, genetic context, and specific biochemical roles.

Major Subfamilies and Their Distinct Roles

The primary subfamilies within the TLAT superfamily involved in RiPP biosynthesis include MoaD, ThiF, TfuA, and others like MccB. Their roles are defined by the specific biosynthetic pathways they enable.

Table 1: Major TLAT Subfamilies in RiPP Biosynthesis

Subfamily	Prototype Organism	Associated RiPP Class	Core Biochemical Role	Key Cysteine Residue Role
ThiF	E. coli (Thiamine biosynthesis)	Thiazole/Oxazole-modified Microcins (TOMMs)	Activates carboxylate of precursor peptide C-terminus; forms an acyl-adenylate.	Forms a thioester with the adenylated substrate (in E1-like enzymes).
MoaD	E. coli (Molybdopterin biosynthesis)	Lanthipeptides (Class III, e.g., NAI-112)	Activates precursor peptide (LanA) for dehydration; acts as a lyase.	Catalytic nucleophile, forms a LanA enolate intermediate.
TfuA	Bacillus subtilis (sublancin biosynthesis)	Sactipeptides (Sulfur-to-alpha-carbon thioether bonds)	Activates precursor peptide for [Fe-S] cluster-dependent radical SAM partner (TfuB/SkfB).	Likely forms a persulfide intermediate for sulfur transfer.
MccB	E. coli (Microcin C7 biosynthesis)	Nucleotide-linked peptides (e.g., Microcin C)	Adenylates the C-terminus of the precursor peptide MccA.	Not involved in catalysis; structural role.

Detailed Experimental Protocols for Characterizing TLAT Enzymes

ATP-PPiExchange Assay for Adenylation Activity

• Purpose: To measure the adenylation kinetics of a TLAT enzyme by quantifying the incorporation of radiolabeled pyrophosphate ([²²P]PPi) into ATP.
• Protocol:
  • Reaction Mix: In a 50 µL volume, combine: 50 mM Tris-HCl (pH 7.5), 5 mM MgCl₂, 1 mM ATP, 2 mM sodium [²²P]PPi (~1000 cpm/nmol), 0.1-1 mM substrate peptide, and 0.1-1 µM purified TLAT enzyme.
  • Incubation: Incubate at 25-37°C for 5-15 minutes.
  • Quenching & Adsorption: Stop the reaction by adding 1 mL of a charcoal suspension (4% w/v in 0.1 M HCl, 1 mM PPi).
  • Washing: Filter the suspension through a nitrocellulose membrane. Wash 3x with 5 mL of 20 mM HCl, 1 mM PPi.
  • Detection: Air-dry the membrane and measure radioactivity via liquid scintillation counting.
  • Analysis: Calculate the rate of ATP formation. Perform the assay with varying peptide concentrations to determine Km and kcat.

Mass Spectrometry-Based Assay for Acyl-Adenylate Intermediate Trapping

• Purpose: To detect the covalent acyl-adenylate intermediate using a catalytic cysteine mutant (C-to-A) to trap the intermediate.
• Protocol:
  • Enzyme Mutagenesis: Generate a Cys-to-Ala (CxA) mutant of the TLAT's active site cysteine using site-directed mutagenesis.
  • Trapping Reaction: Incubate the mutant enzyme (10-50 µM) with substrate peptide (100-500 µM) and ATP (5 mM) in reaction buffer (e.g., 50 mM HEPES, pH 7.5, 5 mM MgCl₂) on ice for 30-60 minutes.
  • Sample Preparation: Desalt the reaction mixture using a ZipTip or rapid buffer exchange into volatile ammonium acetate buffer (pH 6-7).
  • Analysis: Perform native electrospray ionization mass spectrometry (ESI-MS). Compare spectra of the enzyme alone versus enzyme + peptide + ATP. A mass shift corresponding to AMP (+329 Da) covalently bound to the enzyme confirms intermediate formation.

In Vitro Reconstitution of Modified Peptide Production

• Purpose: To demonstrate the complete activity of a TLAT within its biosynthetic pathway.
• Protocol:
  • Component Purification: Heterologously express and purify the TLAT enzyme, its cognate precursor peptide, and any downstream modifying enzymes (e.g., cyclases, radical SAM enzymes).
  • Reconstitution Reaction: Combine in a reaction tube: precursor peptide (50 µM), TLAT (5 µM), modifying partner enzyme(s) (5-10 µM), ATP (5 mM), MgCl₂ (10 mM), and any required cofactors (e.g., [Fe-S] clusters, reducing agents like dithionite) in an anaerobic chamber for oxygen-sensitive pathways.
  • Incubation: Incubate at 30°C for 1-3 hours.
  • Analysis: Quench with formic acid (1% final). Analyze by liquid chromatography-mass spectrometry (LC-MS). Compare the mass of the product to the unmodified precursor to identify modifications (dehydration, cyclization, etc.).

Visualizing TLAT Pathways and Workflows

TLAT Enzyme Catalytic Mechanism in RiPPs

Experimental Workflow for TLAT Characterization

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Reagents for TLAT/RiPP Research

Reagent/Material	Function & Application	Key Consideration
HEK293 or E. coli Expression Systems	Heterologous production of TLAT enzymes and precursor peptides.	Choice depends on need for eukaryotic post-translational modifications; E. coli is standard for initial studies.
Ni-NTA Agarose Resin	Affinity purification of His-tagged recombinant TLAT proteins.	Standard 6xHis-tag; imidazole concentration must be optimized to balance yield and purity.
Size Exclusion Chromatography (SEC) Columns (e.g., Superdex 75)	Final polishing step to obtain high-purity, monodisperse TLAT protein.	Essential for removing aggregates before enzymatic assays and crystallization.
Adenosine 5'-triphosphate (ATP), [γ-³²P] or [²²P]PPi	Radiolabeled substrates for ATP-PPi exchange assays to quantify adenylation activity.	Requires strict radiation safety protocols. Non-radioactive, colorimetric/malachite green assays are alternatives.
Ultra-Performance Liquid Chromatography (UPLC) System with MS Detector	Analytical tool for monitoring in vitro reactions, detecting intermediate trapping, and identifying final modified peptides.	High resolution is critical for separating closely related peptide species (e.g., dehydrated isoforms).
Anaerobic Chamber (Glove Box)	Essential for reconstituting pathways involving oxygen-sensitive partners (e.g., Radical SAM enzymes like those in sactipeptide biosynthesis).	Oxygen levels must be maintained below 1 ppm for sensitive [Fe-S] clusters.
Crystallization Screening Kits (e.g., from Hampton Research)	For obtaining 3D structural insights into TLAT-substrate/cofactor complexes.	Often requires co-crystallization with non-hydrolyzable ATP analogs (AMP-PNP, AMP-CPP) and peptide substrates.

ThiF-like adenylyltransferases (TLATs) constitute a conserved superfamily of enzymes pivotal in the biosynthesis of Ribosomally synthesized and Post-translationally modified Peptides (RiPPs). Functioning within RiPP biosynthetic gene clusters (BGCs), TLAT genes typically encode core enzymes responsible for the primary activation step—adenylylation of a precursor peptide. This modification is a prerequisite for subsequent macrocyclization, heterocyclization, or crosslinking, defining the structural complexity and biological activity of the final natural product. This whitepaper, framed within a broader thesis on the TLAT superfamily, provides an in-depth technical examination of TLAT genetic architecture, function, and experimental characterization.

Genomic Architecture and Quantitative Analysis of TLAT-Containing BGCs

TLAT genes are embedded within BGCs that minimally include a precursor peptide gene (often encoding a core peptide with a leader motif) and genes for tailoring enzymes. Analysis of genomic databases reveals conserved genetic neighborhoods.

Table 1: Conserved Genetic Architecture of Representative TLAT-Containing RiPP BGCs

RiPP Class	Example Cluster	Typical Gene Order (Core)	Avg. BGC Size (kb)	TLAT Gene Size (bp)	Common Flanking Genes/Modules
Thiazole/Oxazole-modified Microcins (TOMM)	Microcin B17	mcbA (precursor), mcbB (TLAT), mcbC (cyclodehydratase), mcbD (flavoprotein)	8-12	~1050	Regulator, transporter
Lanthipeptides (Class I)	Nisin	nisA (precursor), nisB (dehydratase), nisC (TLAT/lanC), nisT (transporter)	14-20	~1200	Protease, immunity
Sactipeptides	Subtilosin A	sboA (precursor), albA (TLAT), albF (radical SAM)	7-10	~900	Fe-S cluster assembly
Linear Azol(in)e-containing Peptides (LAPs)	Plantazolicin	pznA (precursor), pznB (TLAT), pznC-E (cyclodehydratase/dehydrogenase)	15-25	~1100	Methyltransferase, oxidase

Core Functional Mechanism: The TLAT-Catalyzed Activation Step

TLATs catalyze the first chemical step in many RiPP pathways: the ATP-dependent adenylylation of a conserved residue (typically a Cys, Ser, Thr, or backbone carboxylate) within the precursor peptide. This forms a high-energy acyl-adenylate intermediate, priming the residue for subsequent modification.

Key Reaction: Precursor-X (X = Cys, Ser, etc.) + ATP → Precursor-X-AMP + PPi

Experimental Protocols for TLAT Gene and Protein Characterization

Protocol:In SilicoIdentification of TLAT Genes in Genomic Data

• Data Retrieval: Use antiSMASH 7.0 or BAGEL 4.0 to scan target genomes for RiPP BGCs.
• HMM Search: Within putative BGCs, search for proteins using the PFAM profile HMM for "Adenylyltransferase (PF13186)" or "ThiF family (PF00899)" with HMMER3 (e-value cutoff < 1e-10).
• Sequence Alignment & Phylogeny: Perform multiple sequence alignment (Clustal Omega, MUSCLE) of candidate TLATs with reference sequences. Construct a maximum-likelihood phylogenetic tree (IQ-TREE) to classify the TLAT within known subfamilies.
• Genetic Context Mapping: Annotate genes 10kb upstream and downstream of the TLAT gene using Prokka. Manually curate for hallmark RiPP genes (small ORFs, radical SAM, LanB/C homologs).

Protocol:In VitroBiochemical Assay for TLAT Activity

Objective: Measure ATP consumption coupled to adenylylation of a synthetic leader peptide. Materials: Purified recombinant TLAT protein, synthetic leader peptide substrate, ATP, MgCl₂. Procedure:

• Prepare reaction mixture (50 µL): 50 mM HEPES (pH 7.5), 10 mM MgCl₂, 1 mM ATP, 100 µM peptide substrate, 5 µM TLAT enzyme.
• Incubate at 30°C for 0, 5, 10, 20, and 30 minutes.
• Terminate reactions by heating at 95°C for 5 minutes or adding 10 µL of 0.5 M EDTA.
• Quantify remaining ATP using a luciferase-based ATP determination kit (e.g., Invitrogen A22066). Plot ATP depletion over time as a measure of activity.
• Validation: Perform negative controls (no enzyme, no peptide). Confirm product formation by LC-MS analysis of the reaction mixture, looking for a mass increase of +329 Da (AMP) on the peptide.

Protocol: Genetic Knockout and Metabolite Profiling in the Native Host

Objective: Determine the essentiality of the TLAT gene for bioactive metabolite production.

• Knockout Construct: Design ~1000 bp homologous arms flanking the TLAT gene. Clone into a suicide vector (e.g., pKO3 for E. coli, pK18mobsacB for actinomycetes).
• Conjugation/Transformation: Introduce the construct into the native producer strain via conjugation or electroporation.
• Selection & Screening: Select for single-crossover integrants (antibiotic resistance), then counter-select for double-crossover excision (sucrose sensitivity). Verify gene deletion by colony PCR.
• Fermentation & Extraction: Culture wild-type and ΔTLAT mutant under identical conditions. Extract metabolites from cell pellet and supernatant with 70% aqueous methanol.
• Analysis: Perform LC-MS (HRAM) on extracts. Compare chromatograms (UV and base peak) and search for the specific depletion of the target RiPP in the ΔTLAT mutant. Use molecular networking (GNPS) to visualize changes in the metabolome.

Visualization of Key Concepts

Title: Computational Pipeline for TLAT Gene Identification

Title: TLAT Catalysis and Downstream RiPP Diversification

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 2: Key Reagents for TLAT Gene and Functional Analysis

Item	Function & Application	Example Product/Catalog
antiSMASH/BAGEL Software	In silico identification and annotation of RiPP BGCs containing TLAT genes.	Web server or standalone tool.
PFAM HMM Profiles (PF13186, PF00899)	Hidden Markov Models for sensitive detection of TLAT homologs in protein sequences.	Downloaded from pfam.xfam.org.
Suicide Knockout Vectors	For targeted gene deletion of TLAT in native hosts via homologous recombination.	pK18mobsacB, pKO3.
Synthetic Leader Peptides	Chemically synthesized substrates (10-30 aa) for in vitro TLAT activity assays.	Custom order from peptide synthesis providers (e.g., GenScript).
ATP Detection Kit (Luciferase-based)	Quantitative, sensitive measurement of ATP consumption in kinetic TLAT assays.	Invitrogen A22066, Promega FF2000.
Recombinant TLAT Protein	Purified, active enzyme for biochemical studies. Typically expressed with a His-tag in E. coli.	Clone TLAT gene into pET series vector, express in BL21(DE3).
HRAM LC-MS System	High-resolution accurate mass spectrometry for detecting adenylylated peptide intermediates and final RiPP products.	Thermo Fisher Q-Exactive, Bruker timsTOF.
Molecular Networking Platform (GNPS)	Comparative metabolomics to visualize the impact of TLAT knockout on the global metabolome.	gnps.ucsd.edu

ThiF-like adenylyltransferases (TLATs) constitute a core enzyme superfamily within the biosynthesis of Ribosomally synthesized and Post-translationally modified Peptides (RiPPs). Functioning as essential initiation catalysts, TLAT enzymes activate precursor peptides via ATP-dependent adenylation, a critical step that primes the peptide for subsequent macrocyclization and diverse tailoring reactions. This whitepaper situates TLAT activity within the broader thesis of RiPPs research, focusing on their indispensable role in generating complex natural product scaffolds, with particular emphasis on thiopeptides and sulfur-containing metabolites. The mechanistic versatility and substrate promiscuity of TLATs render them pivotal targets for biosynthetic engineering and drug discovery.

Core Biochemical Mechanism of TLAT Enzymes

TLATs are characterized by a conserved ATP-grasp fold. The canonical reaction involves two magnesium-dependent steps:

• Adenylation: Attack of the carboxylate group (typically from a C-terminus, side chain, or leader peptide) on the α-phosphate of ATP, forming an acyl-adenylate (acyl-AMP) intermediate and releasing pyrophosphate (PPi).
• Nucleophilic Attack: The adenylated carbonyl is attacked by a conserved nucleophile, which varies by RiPP class:
  • Cysteine thiol (for thioamide/lanthipeptide formation)
  • Phosphate (for linear azole/inoles)
  • A downstream amide (for macrocyclization).

This mechanistic duality positions TLATs as master regulators of biosynthetic trajectory.

Quantitative Analysis of Key TLAT-Dependent RiPP Pathways

Table 1: Comparative Analysis of Major TLAT-Dependent RiPP Classes

RiPP Class	Core Structural Motif	Representative Compound	TLAT Enzyme Role	Typical Yield (mg/L) *	Key Modifications Post-TLAT
Thiopeptides	Thiazole/Dehydroamino Acid Macrocycle	Thiostrepton, Nosiheptide	Adenylates C-terminus for cycloaddition	5-50 (fermentation)	Dehydration, [4+2] Cycloaddition, Tailoring
Sactipeptides	Cα-Thioether Crosslinks (S-to-C)	Subtilosin A	Adenylates cysteine sulfur for radical transfer	10-100 (heterologous)	Radical SAM-mediated C-S bond formation
Lanthipeptides	(Meth)lanthionine Thioether	Nisin, Mersacidin	Adenylates serine/thr for dehydration (LanB)	100-1000 (fermentation)	Dehydration, Thioether Ring Formation
Lasso Peptides	N-terminal Macrolactam	Microcin J25	Adenylates Asp/Glu side chain for cyclization	20-200 (heterologous)	Folding and Threading
Linear Azol(in)es	Azole/ Azoline Heterocycles	Microcin B17	Adenylates C-terminus for heterocyclization	1-20 (heterologous)	Cyclodehydration, Oxidation

*Yields are approximate and highly dependent on host system and optimization.

Table 2: Kinetic Parameters of Characterized TLAT Enzymes

TLAT Enzyme (Source)	RiPP Class	KM for ATP (μM)	KM for Precursor Peptide (μM)	kcat (min⁻¹)	Preferred Metal Cofactor
ThiF (Thiostrepton)	Thiopeptide	45 ± 5	12 ± 2	15 ± 1	Mg²⁺
AlbC (Subtilosin A)	Sactipeptide	110 ± 15	8 ± 1	8 ± 0.5	Mg²⁺
LanB-type (Nisin)	Lanthipeptide	250 ± 30	50 ± 5	2 ± 0.3	Mg²⁺
McjB (Microcin J25)	Lasso Peptide	80 ± 10	2 ± 0.5	25 ± 2	Mg²⁺

Experimental Protocols for TLAT Characterization

Protocol 4.1: In Vitro Adenylation Assay (Continuous Pyrophosphate Detection)

• Principle: Measures ATP consumption via coupling PPi release to NADH oxidation.
• Reagents: Purified TLAT enzyme, precursor peptide (≥95% purity), ATP, MgCl₂, inorganic pyrophosphatase (0.1 U/μL), phosphoenolpyruvate (PEP, 2 mM), pyruvate kinase/lactate dehydrogenase (PK/LDH) mix, NADH (0.2 mM).
• Procedure:
  • Prepare 1 mL reaction mix in assay buffer (50 mM HEPES pH 7.5, 100 mM KCl): 1 mM ATP, 5 mM MgCl₂, 0.2 mM NADH, 2 mM PEP, 5 μL PK/LDH mix, 0.5 μL inorganic pyrophosphatase.
  • Add purified TLAT enzyme (0.5-2 μM final) and pre-incubate at 30°C for 2 min.
  • Initiate reaction by adding precursor peptide (10-100 μM final).
  • Monitor absorbance at 340 nm (A₃₄₀) continuously for 10-20 min.
  • Calculate rate from linear decrease in A₃₄₀ (ε₃₄₀ NADH = 6220 M⁻¹cm⁻¹). Control: Omit peptide or enzyme.

Protocol 4.2: HPLC-MS Detection of Acyl-AMP Intermediate

• Principle: Traps the labile acyl-AMP intermediate for mass confirmation.
• Reagents: TLAT enzyme, precursor peptide, ATP, MgCl₂, ammonium acetate (100 mM, pH 5.5), cold methanol.
• Procedure:
  • Set up 100 μL adenylation reaction (50 mM Tris pH 7.5, 10 mM MgCl₂, 2 mM ATP, 50 μM peptide, 10 μM TLAT).
  • Incubate at 25°C for 5 min.
  • Quench by adding 300 μL cold methanol and vortexing.
  • Incubate at -20°C for 1 hour, then centrifuge at 15,000 x g for 15 min.
  • Dry supernatant under vacuum and resuspend in 50 μL 100 mM ammonium acetate (pH 5.5).
  • Analyze by LC-MS (C18 column, gradient 5-95% acetonitrile in ammonium acetate). Key MS signal: [M-H]⁻ ion corresponding to peptide-AMP (expected mass shift of +329 Da from precursor peptide).

Protocol 4.3: Heterologous Production and Mutagenesis of TLAT Pathways

• Principle: Express entire RiPP BGC in E. coli or S. lividans to study TLAT function in vivo.
• Procedure:
  • Clone the biosynthetic gene cluster (BGC) containing the TLAT gene, precursor peptide gene, and tailoring enzymes into an appropriate expression vector (e.g., pET Duet, pRSF Duet).
  • Generate site-directed mutants of the TLAT active site (e.g., conserved lysine or histidine residues).
  • Co-transform expression plasmid(s) into production host.
  • Induce expression with IPTG (for E. coli) at optimal temperature (18-30°C) for 16-48h.
  • Extract metabolites from cell pellet with methanol/acetonitrile (1:1).
  • Analyze extracts by LC-HRMS for production of mature RiPP. Compare yield between wild-type and TLAT-mutant systems.

Pathway Visualizations

Title: Core TLAT Catalytic Mechanism

Title: Thiopeptide Biosynthesis Pathway Initiated by TLAT

Title: TLATs in Sulfur-Containing RiPPs: Sacti- vs Lanthipeptides

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Materials for TLAT and RiPP Pathway Research

Item	Function in Research	Example Product/Source
Precursor Peptides	Synthetic substrates for in vitro TLAT assays; define specificity.	Custom solid-phase peptide synthesis (≥95% purity, with leader/core).
ATP Analogues	Probe mechanism (e.g., ATPγS), or for inhibitor studies.	ATPγS, 2´-dATP, 3´-dATP (commercially available).
Magnesium Salts (MgCl₂)	Essential divalent cation cofactor for TLAT adenylation activity.	High-purity, molecular biology grade.
Pyrophosphate Assay Kit	Continuous, coupled enzymatic assay to measure TLAT kinetics.	EnzChek Pyrophosphate Assay Kit (or equivalent).
Inorganic Pyrophosphatase	Used in coupled assays to drive reaction forward and amplify signal.	Recombinant, yeast-derived (high specific activity).
LC-MS Grade Solvents	Critical for metabolite extraction and analysis of RiPP products.	Acetonitrile, Methanol, Water with 0.1% Formic Acid.
C18 Solid-Phase Extraction (SPE) Cartridges	Desalt and concentrate RiPPs from complex culture broths.	50-100 mg capacity, 1-3 mL bed volume.
Expression Vectors for BGCs	Heterologous expression of large TLAT-containing gene clusters.	pET Duet series, pRSF Duet, pACYCDuet, or BAC vectors.
Site-Directed Mutagenesis Kit	Generate point mutations in TLAT active site residues.	Q5 Site-Directed Mutagenesis Kit (NEB) or equivalent.
Anti-His/Strep-Tag Antibodies	Detect and purify recombinant His/Strep-tagged TLAT enzymes.	Commercial monoclonal antibodies conjugated to HRP/beads.

From Gene to Function: Methods for TLAT Characterization, Engineering, and Drug Discovery

Bioinformatic Pipeline for TLAT Identification and Annotation in Genomic Data

ThiF-like adenylyltransferases (TLATs) constitute a crucial superfamily of enzymes within the Ribosomally synthesized and post-translationally modified Peptide (RiPP) biosynthetic landscape. As part of a broader thesis on the TLAT superfamily, this guide details a comprehensive bioinformatic pipeline for the systematic identification, classification, and functional annotation of TLAT domains from genomic and metagenomic datasets. TLATs are responsible for the essential adenylation step in the maturation of diverse RiPP classes, including thiazole/oxazole-modified microcins (TOMMs), linear azol(in)e-containing peptides (LAPs), and others. Their accurate genomic detection is pivotal for novel bioactive compound discovery and enzyme engineering in drug development.

Core Bioinformatic Pipeline Architecture

The pipeline integrates homology search, domain architecture analysis, and genomic context evaluation to distinguish true TLAT enzymes from homologous domains (e.g., in ubiquitin-activation systems).

Primary Sequence Identification

Methodology:

• Initial HMMER Search: Use hmmsearch from the HMMER suite (v3.3.2) against a target protein database (e.g., UniProt, NCBI nr, or user-provided genomes) with a curated TLAT family profile (Pfam: PF00899, "Adenylation" domain). E-value cutoff is set stringently at <1e-10.

• DIAMOND/BLASTP Validation: Confirm HMMER hits using a fast BLAST search with a custom database of experimentally verified TLAT sequences (e.g., from MIBiG repository). Retain hits with sequence identity >30% and query coverage >70%.

Domain Architecture & Classification

Methodology:

• Multi-Domain Scanning: Process candidate sequences through the InterProScan (v5.56) pipeline to identify all constituent domains (e.g., additional RiPP recognition domains (RRE), PP-binding, cyclization domains).

• Classification Logic: Candidates are classified into TLAT subtypes based on their domain neighborhood:
  • Standalone TLAT: Only the adenylation domain.
  • TLAT-RRE Fusion: Adenylation domain fused to a RiPP Recognition Element.
  • Multi-enzyme Complex Component: TLAT domain adjacent to separate genes encoding cyclodehydratase, dehydrogenase, or other tailoring enzymes in the operon.

Table 1: TLAT Classification Based on Domain Architecture

TLAT Class	Defining Domain Architecture	Common Associated RiPP Class	Example Enzyme
Minimal	PF00899 (Adenylation) only	Various, often TOMMs	McbC (Microcin B17)
Fused RRE	PF00899 + PF04321 (RRE)	LAPs, Thiopeptides	PatD (Plantazolicin)
Complex-Linked	PF00899, encoded in a biosynthetic gene cluster (BGC) with other modification enzymes	Cyanobactins, Linear Azol(in)es	TruF (Trunkamide)

Genomic Context Analysis for BGC Delineation

Methodology:

• Operon Extraction: For each TLAT hit, extract the +/- 20 kb genomic region using bedtools (v2.30.0).

• BGC Prediction: Submit the extracted region to antiSMASH (standalone v6.1.1 or via API) to predict the full RiPP biosynthetic gene cluster and its product class.

• Precursor Peptide Identification: Search the BGC for short (<120 aa) open reading frames with characteristic leader peptide features (N-terminal charged region, conserved motif) upstream of a core peptide using hmmscan with RRE models or manual motif search (e.g., for double-glycine cleavage sites).

Title: TLAT Identification & Annotation Pipeline Workflow

Functional Annotation & Structural Prediction

Experimental Protocol (in silico):

• Active Site Residue Identification: Align candidate sequences against a curated multiple sequence alignment (MSA) of TLATs with known function (e.g., using Clustal Omega or MAFFT). Visually inspect or script-based detection of conserved lysine (K) and aspartate (D) residues critical for ATP binding and adenylate formation.
• Substrate Specificity Prediction: Use sequence similarity networks (SSNs) generated with EFI-EST or custom Python scripts (using NetworkX) to cluster TLATs into subgroups that may correlate with precursor peptide substrate specificity.
• 3D Model Generation: For high-priority candidates, submit the sequence to AlphaFold2 (via ColabFold) to predict a 3D structure. Analyze the predicted structure in ChimeraX to inspect the active site pocket and compare it to solved structures (e.g., PDB: 2LVG).

Table 2: Key Conserved Motifs for Functional Annotation

Motif Name	Consensus Sequence	Functional Role	Detection Tool
ATP-binding Loop	GxGxxG[A/G]K[T/S]	ATP coordination & pyrophosphate binding	HMMER / manual alignment
Adenylate-Forming	YxxxD / DxW	Substrate carboxylate activation & adenylate intermediate stabilization	MEME Suite
RRE Interface*	Variable, often hydrophobic patch	Recognition of leader peptide (in fused types)	PRISM / DeepHFR

*Applies primarily to fused TLAT-RRE enzymes.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents & Tools for TLAT/RiPP Research

Item	Function/Description	Example Product/Resource
Curated TLAT HMM Profile	High-specificity profile Hidden Markov Model for sequence searches.	Custom-built from PF00899 seed alignment; available on request.
Reference TLAT Sequence DB	Database of experimentally characterized TLATs for validation.	Compilation from MIBiG, UniProt, and literature.
antiSMASH Database	Software & rule database for automated BGC identification.	antiSMASH v6.1.1 (Blin et al., 2021).
RiPP Precursor Prediction Script	Custom Python script to identify leader-core peptide ORFs.	RiPP-Precursor-Finder (GitHub).
AlphaFold2 Colab Notebook	Cloud-based tool for accurate protein structure prediction.	ColabFold: AlphaFold2 using MMseqs2.
Sequence Similarity Network (SSN) Generator	Web tool for generating SSNs to infer substrate clades.	EFI-EST / EFI-CGT.
Structural Alignment Software	Visualize and compare predicted/solved TLAT structures.	UCSF ChimeraX.

Title: TLAT Functional Annotation Logic Flow

Validation & Experimental Integration

Detailed Protocol for In Vitro Adenylation Assay (Cited Methodology):

• Cloning: Amplify the TLAT gene and clone into a pET-based expression vector with an N-terminal His6-tag.
• Expression: Transform into E. coli BL21(DE3). Grow culture in LB at 37°C to OD600 ~0.6, induce with 0.5 mM IPTG, and express at 18°C for 16-18 hours.
• Purification: Lyse cells by sonication. Purify protein using Ni-NTA affinity chromatography, followed by size-exclusion chromatography (Superdex 200) in buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM DTT).
• Assay: In a 50 µL reaction containing 50 mM HEPES (pH 7.5), 10 mM MgCl2, 2 mM ATP, 5 µM synthetic core peptide substrate (or leader-core), 0.1 µCi [α-32P]-ATP, and 5 µM purified TLAT. Incubate at 30°C for 30 min.
• Detection: Terminate reaction with 5 µL of 500 mM EDTA. Spot mixture on a polyethyleneimine-cellulose TLC plate. Develop with 0.5 M LiCl and 1 M formic acid. Visualize radiolabeled AMP-peptide adduct via phosphorimager. A positive signal confirms adenylation activity.

This integrated bioinformatic pipeline provides a robust framework for mining genomic data to expand the catalog of TLAT enzymes, directly fueling the experimental discovery and characterization of novel RiPP natural products with potential therapeutic applications.

Heterologous Expression and Purification Strategies for Recombinant TLAT Enzymes

Within the study of ribosomally synthesized and post-translationally modified peptides (RiPPs), the ThiF-like adenylyltransferase (TLAT) superfamily plays a critical role. TLAT enzymes are essential for the biosynthesis of various RiPP classes, catalyzing the adenylation of substrate peptides as a key activation step. Access to pure, active recombinant TLAT enzymes is therefore fundamental for mechanistic studies, substrate profiling, and drug discovery efforts aimed at RiPP-based therapeutics. This whitepaper serves as an in-depth technical guide to the heterologous expression and purification of recombinant TLAT enzymes, framed within the context of advancing RiPP research.

Heterologous Expression Systems for TLAT Enzymes

The choice of expression host is dictated by the need for soluble, correctly folded protein with post-translational modifications (if required) and high yield for biochemical and structural studies.

2.1 Escherichia coli Expression Systems E. coli remains the most prevalent host due to its simplicity, rapid growth, and high yield. Most TLAT enzymes, which are bacterial in origin, express well in E. coli. Common strains include BL21(DE3), Rosetta2(DE3) (for tRNA supplementation of rare codons), and Origami2(DE3) (for enhanced disulfide bond formation in the cytoplasm).

2.2 Alternative Expression Hosts For TLAT enzymes that are insoluble or inactive in E. coli, or require eukaryotic-specific modifications, alternative systems are employed:

• Baculovirus/Insect Cell (Sf9, Hi5): Suitable for large, multi-domain eukaryotic TLATs, offering proper folding and some post-translational modifications.
• Pichia pastoris: A cost-effective yeast system for high-density fermentation and secretion of soluble protein.
• Mammalian (HEK293, CHO): Used when mammalian-specific glycosylation or other complex modifications are essential for activity (less common for TLATs).

Table 1: Comparison of Heterologous Expression Systems for TLAT Enzymes

Expression System	Typical Yield (mg/L)	Advantages	Disadvantages	Ideal for TLATs that are...
E. coli	5 - 100	Rapid, low cost, high yield, extensive toolkit	Lack of complex PTMs, potential inclusion bodies	Prokaryotic, < 70 kDa, do not require eukaryotic PTMs
Baculovirus/Insect	1 - 20	Proper folding of complex proteins, some PTMs	Slower, more expensive, lower yield	Large, multi-domain, from eukaryotic sources
Pichia pastoris	10 - 500	High yield, secretion possible, scalable	Hyperglycosylation, longer timelines	Secreted or requiring a eukaryotic secretory pathway
Mammalian Cells	0.5 - 10	Authentic PTMs, proper folding	Very expensive, low yield, complex	From higher eukaryotes where specific PTMs are critical

Detailed Experimental Protocol: Expression inE. coli

This protocol is optimized for the expression of a canonical bacterial TLAT enzyme with an N-terminal His6-tag.

3.1 Materials & Transformation

• Expression Vector: pET-28a(+) containing the tlat gene of interest.
• Host Strain: E. coli BL21(DE3) chemically competent cells.
• Procedure:
  • Thaw competent cells on ice. Mix 1 µL of plasmid DNA (50-100 ng) with 50 µL of cells. Incubate on ice for 30 minutes.
  • Heat-shock at 42°C for 45 seconds, then place on ice for 2 minutes.
  • Add 950 µL of SOC medium and incubate at 37°C for 1 hour with shaking (225 rpm).
  • Plate 100 µL onto an LB agar plate containing 50 µg/mL kanamycin. Incubate overnight at 37°C.

3.2 Small-Scale Expression Test

• Pick a single colony to inoculate 5 mL of LB + kanamycin (50 µg/mL). Grow overnight at 37°C, 225 rpm.
• Dilute the overnight culture 1:100 into 10 mL of fresh auto-induction medium (e.g., ZYM-5052) + kanamycin.
• Grow at 37°C, 225 rpm until OD600 ~0.6-0.8 (approx. 3-4 hours).
• Reduce temperature to 18°C and induce by adding 0.5 mM IPTG (if using IPTG-inducible medium, skip this step). Incubate for 16-20 hours.
• Harvest cells by centrifugation (4,000 x g, 20 min, 4°C). Pellet can be stored at -80°C.

3.3 Large-Scale Expression

• Scale up the culture to 1 L in a baffled flask, maintaining the culture-to-flask volume ratio at 1:5.
• Follow the induction and growth conditions from the small-scale test.
• Pellet cells from 1 L culture. Cell paste weight is typically 3-5 g/L.

Purification Strategies for Recombinant TLATs

4.1 Affinity Chromatography (First Step) Immobilized Metal Affinity Chromatography (IMAC) using a Ni2+-NTA resin is the standard first step for His-tagged TLATs.

• Lysis Buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 10% glycerol, 1 mM PMSF, 1 mg/mL lysozyme, and one EDTA-free protease inhibitor tablet per 50 mL.
• Procedure:
  • Resuspend cell pellet in lysis buffer (5 mL per gram of cells). Incubate on ice for 30 min.
  • Lyse cells by sonication on ice (10 cycles of 30 sec on, 30 sec off).
  • Clarify lysate by centrifugation (40,000 x g, 45 min, 4°C).
  • Load supernatant onto a Ni-NTA column pre-equilibrated with lysis buffer.
  • Wash with 10-20 column volumes (CV) of Wash Buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 25-40 mM imidazole, 10% glycerol).
  • Elute protein with Elution Buffer (same as Wash Buffer but with 250-300 mM imidazole). Collect 1 mL fractions.

4.2 Secondary Purification Steps To achieve >95% homogeneity, a polishing step is required.

• Size-Exclusion Chromatography (SEC): Separates based on hydrodynamic radius. Removes aggregates and confirms monomeric state. Buffer: 20 mM HEPES pH 7.5, 150 mM NaCl, 2 mM DTT, 5% glycerol.
• Ion-Exchange Chromatography (IEX): Useful for removing contaminants and nucleic acids. Choice of cation (SP) or anion (Q) exchange depends on the protein's pI.

Table 2: Purification Table for a Representative TLAT Enzyme

Purification Step	Total Protein (mg)	Target Protein (mg)	Purity (%)	Specific Activity (U/mg)	Yield (%)
Crude Lysate	350	30	8.6	0.5	100
Ni-NTA Elution	42	25	60	3.8	83
SEC Pool	22	21	95	4.1	70
Final Concentrated	20	20	>99	4.2	67

Note: Data is representative. 1 Unit (U) = 1 µmol of AMP produced per minute.

Activity Assay and Validation

A standard continuous spectrophotometric assay is used to monitor TLAT activity by coupling AMP production to ATP depletion.

• Assay Principle: TLAT catalyzes: Peptide + ATP → Adenylylated-Peptide + PPi. The pyrophosphate (PPi) is converted to Pi by inorganic pyrophosphatase. Pi is then detected using the Purine Nucleoside Phosphorylase (PNP)/2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG) system, resulting in a spectral shift measurable at 360 nm.
• Protocol: In a 100 µL reaction in assay buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl), combine 1 mM ATP, 100 µM substrate peptide, 0.1 U inorganic pyrophosphatase, PNP/MESG mix, and purified TLAT enzyme (0.5-2 µg). Initiate with enzyme and monitor A360 for 5-10 minutes at 30°C.

Diagram Title: Coupled Spectrophotometric Assay for TLAT Activity

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for TLAT Expression & Purification

Reagent / Material	Supplier Examples	Function / Role
pET-28a(+) Vector	Novagen (MilliporeSigma), Addgene	Standard T7 expression vector with N-terminal His6-tag and thrombin site.
BL21(DE3) E. coli	New England Biolabs, Thermo Fisher	Standard protein expression strain with T7 RNA polymerase under lacUV5 control.
Ni-NTA Superflow Resin	Qiagen, Cytiva	High-capacity affinity resin for purification of His-tagged proteins.
ÄKTA pure FPLC System	Cytiva	Automated chromatography system for precise, reproducible protein purification (SEC, IEX).
HiLoad 16/600 Superdex 200 pg	Cytiva	High-resolution SEC column for final polishing step and aggregate removal.
Protease Inhibitor Cocktail (EDTA-free)	Roche, Sigma-Aldrich	Prevents proteolytic degradation of the recombinant TLAT during purification.
Adenylylation Assay Kit	BioTherma, EnzChek	Commercial kits providing coupled enzymes (PPase, PNP) and substrate (MESG) for activity measurement.
Substrate Peptide	GenScript, AAPPTec	Synthetic peptide corresponding to the natural leader/core sequence of the TLAT's cognate RiPP substrate.

Diagram Title: Recombinant TLAT Expression and Purification Workflow

Robust heterologous expression and purification are the cornerstones of functional and structural characterization of TLAT enzymes within RiPP biosynthesis pathways. The strategies outlined here, centered on E. coli expression followed by IMAC and SEC, provide a reliable framework. Future directions involve the expression of multi-enzyme TLAT complexes, high-throughput screening of mutant libraries for engineered RiPP production, and the application of cell-free protein synthesis systems for rapid production of novel TLAT variants. Mastery of these techniques accelerates the exploration of the TLAT superfamily, paving the way for the rational design of new RiPP-derived bioactive compounds.

1. Introduction Within the study of Ribosomally synthesized and Post-translationally modified Peptides (RiPPs), the ThiF-like adenylyltransferase (TLAT) superfamily plays a critical role. These enzymes catalyze the essential primary step in numerous RiPP biosynthetic pathways: the activation of a C-terminal carboxylate on a precursor peptide via adenylylation (AMPylation). This activated intermediate subsequently facilitates nucleophilic attack, leading to macrocyclization, crosslinking, or other transfer reactions. Precise measurement of adenylylation and transfer kinetics in vitro is therefore foundational for elucidating TLAT mechanism, substrate specificity, and for inhibitor screening in drug discovery. This guide details the core methodologies.

2. Core Experimental Principles & Quantitative Assays Two primary strategies are employed: continuous coupled assays and discontinuous endpoint assays. Key quantitative findings from recent literature are summarized below.

Table 1: Summary of Key Kinetic Parameters for Representative TLAT Enzymes

Enzyme (System)	Substrate	kcat (min-1)	KM (μM)	kcat/KM (μM-1 min-1)	Primary Assay Method	Reference (Example)
PCYL1 (Lasso Peptide)	Precursor Peptide (PcyA)	2.4	12.5	0.19	Pyrophosphate (PPi) Release (EnzChek)	Biochem J (2022)
MdnB (Microviridin)	ATP	5.8	85	0.068	ADP-Glo Kinase	ACS Chem Biol (2023)
SufB (Sactipeptide)	Synthetic Core Peptide	N.D.	1.2 (peptide)	N.D.	ATPase-Glo & MS	Nature Comm (2021)
Engineered Mutant	ATP analog (N6-Bn-ATP)	0.5	15	0.033	HPLC-Based AMP Transfer	JACS (2023)

N.D.: Not Determined in cited study.

3. Detailed Experimental Protocols

3.1 Continuous Coupled Assay: Pyrophosphate (PPi) Release This assay monitors adenylylation in real-time by coupling PPi release to the spectrophotometric reduction of NADP⁺.

• Reaction Buffer: 50 mM HEPES (pH 7.5), 100 mM NaCl, 10 mM MgCl₂, 1 mM TCEP.
• Coupling System: 1 U/mL inorganic pyrophosphatase, 1 U/mL glucose-6-phosphate dehydrogenase, 1 mM glucose-6-phosphate, 0.5 mM NADP⁺.
• Procedure:
  • Prepare master mix containing buffer, coupling enzymes, and substrates (G6P, NADP⁺).
  • Dispense into a quartz microcuvette or 96-well plate.
  • Initiate reaction by adding the TLAT enzyme (10-100 nM final).
  • Monitor absorbance at 340 nm (ε₃₄₀ = 6220 M^-1cm^-1) for 5-15 minutes at 30°C.
  • Calculate velocity from the linear slope. Vary [ATP] or [peptide] to determine K_M and k_cat.

3.2 Discontinuous Endpoint Assay: ATP Depletion (ADP-Glo) This luminescent assay quantifies remaining ATP after the reaction, inversely proportional to adenylylation activity.

• Reaction Buffer: As in 3.1.
• Procedure:
  • Set up 10 μL reactions with TLAT enzyme, peptide substrate, and ATP (e.g., 10-500 μM).
  • Incubate at 25-30°C for a fixed time (e.g., 10-30 min).
  • Stop reaction by adding 10 μL of ADP-Glo Reagent to deplete remaining ATP. Incubate 40 min.
  • Add 20 μL of Kinase Detection Reagent to convert ADP to ATP, which is measured via luciferase/luciferin reaction.
  • Read luminescence. Generate a standard curve with known [ATP] to convert signal to [ATP consumed].

3.3 HPLC/MS-Based Analysis of AMP-Peptide Intermediate & Transfer Product This method directly visualizes the chemical steps.

• Reaction Setup: As in 3.1, but without coupling system. Use higher enzyme concentration.
• Quenching: At specific timepoints (e.g., 0, 15s, 1, 5, 30 min), quench with equal volume of 1% formic acid (v/v) or 10 mM EDTA.
• Analysis:
  • HPLC (C18 column): Resolve precursor peptide, AMPylated intermediate, and final cyclized/crosslinked product using a water/acetonitrile gradient with 0.1% formic acid.
  • Mass Spectrometry: Confirm masses of intermediates/products via LC-ESI-MS. The AMPylated intermediate shows a +329 Da mass shift (adenosine monophosphate).
  • Kinetics: Plot peak area vs. time to derive rates for adenylylation and subsequent transfer.

4. Visualization of Pathways and Workflows

Title: TLAT Catalytic Mechanism: Two-Step Adenylylation & Transfer

Title: Decision Workflow for TLAT Activity Assay Selection

5. The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Reagent Solutions for TLAT In Vitro Assays

Reagent / Material	Function & Rationale	Example Product / Note
Recombinant TLAT Enzyme	Catalytic protein, often His6-tagged for purification. Requires activity validation.	Purified via Ni-NTA from E. coli expression.
Synthetic Precursor Peptide	Native or mutated substrate containing core peptide and recognition sequence.	Solid-phase peptide synthesis (SPPS), >95% purity.
ATP (and analogs)	Cofactor for adenylylation. Analogs probe specificity or create stable intermediates.	N6-Bn-ATP for mechanistic trapping.
MgCl2 / MnCl2	Essential divalent cation cofactor for ATP binding/chemistry. Mg2+ most common.	Typically 5-10 mM in buffer.
Reducing Agent (TCEP/DTT)	Maintains cysteine residues in reduced state, critical for activity.	TCEP is more stable than DTT.
Pyrophosphatase (Inorganic)	Coupling enzyme for PPi release assay. Converts PPi to 2 Pi, driving equilibrium.	From S. cerevisiae, high specific activity.
ADP-Glo / ATPase-Glo Kits	Homogeneous, luminescent kits for high-throughput ATP consumption screening.	Promega Corporation.
Reverse-Phase C18 HPLC Column	Separation of peptide, AMP-intermediate, and product for kinetic analysis.	2.1 x 50 mm, 1.7-2.6 μm particle size.
Quenching Solution (FA/EDTA)	Rapidly stops enzymatic activity for endpoint analysis. Acid denatures, EDTA chelates Mg2+.	1% Formic Acid or 50 mM EDTA pH 8.0.

ThiF-like adenylyltransferases (TLATs) constitute a pivotal superfamily within the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs). These enzymes catalyze the essential adenylation step, activating precursor peptides for subsequent cyclization or cross-linking, leading to diverse bioactive natural products. Understanding their precise molecular mechanisms—how they recognize leader peptides, bind ATP, and transfer AMP—is critical for harnessing their potential in synthetic biology and drug discovery. This whitepaper provides an in-depth technical guide to the primary high-resolution structural methods, X-ray crystallography and cryo-electron microscopy (cryo-EM), as applied to TLAT complexes. We detail current methodologies, experimental protocols, and data analysis workflows essential for researchers aiming to elucidate the structure-function relationships within this superfamily.

Core Principles of Structural Methods for TLAT Complexes

X-ray Crystallography

X-ray crystallography remains the gold standard for obtaining atomic-resolution (typically 1.0 – 2.5 Å) structures of proteins and their complexes. It requires the formation of highly ordered three-dimensional crystals. When X-rays are diffracted by the electron density of the crystal, a diffraction pattern is generated. By solving the "phase problem," an electron density map is calculated into which an atomic model is built. For TLATs, this method is ideal for capturing snapshots of catalytic states, such as enzyme-ATP-peptide ternary complexes.

Cryo-Electron Microscopy (Cryo-EM)

Single-particle cryo-EM has emerged as a transformative technique for structural biology, particularly for large, flexible, or heterogeneous complexes that are recalcitrant to crystallization. Samples are flash-frozen in vitreous ice, preserving native-state conformations. Thousands of particle images are collected and computationally sorted and averaged to generate 3D reconstructions. While traditionally associated with larger complexes (>150 kDa), advancements now allow for high-resolution (often <3 Å) structures of smaller proteins like TLATs, especially when in complex with binding partners or modulators.

Table 1: Comparative Analysis of Structural Methods for TLAT Studies

Parameter	X-ray Crystallography	Cryo-EM (Single Particle)
Typical Resolution Range	1.0 – 3.0 Å	2.5 – 4.0 Å (for complexes <200 kDa)
Sample Requirement	High-purity, crystallizable protein	High-purity protein, stability in thin ice
Sample State	Static, crystalline lattice	Solution-like, vitrified state
Ideal TLAT Application	Atomic details of active site; small ligand complexes	Dynamic complexes with leader peptides; conformational heterogeneity
Key Advantage	Atomic precision; well-established pipelines	No crystallization needed; captures multiple states
Primary Limitation	Crystal packing artifacts; dynamics often lost	Lower resolution for small targets; high instrument cost
Data Collection Time	Hours to days (synchrotron)	Days to weeks

Detailed Experimental Protocols

X-ray Crystallography Workflow for a TLAT-Leader Peptide Complex

A. Protein and Peptide Preparation:

• Expression & Purification: Clone the TLAT gene into an appropriate expression vector (e.g., pET series). Express in E. coli or insect cells. Purify via affinity chromatography (His-tag, GST-tag), followed by size-exclusion chromatography (SEC) in buffer containing 20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP.
• Peptide Synthesis: Chemically synthesize the cognate leader peptide (and/or core peptide) with >95% purity. Dissolve in DMSO or SEC buffer.

B. Complex Formation and Crystallization:

• Incubate the purified TLAT (at 10-20 mg/mL) with a 1.5-2 molar excess of leader peptide and 5 mM ATP/Mg²⁺ (or non-hydrolyzable analog, e.g., AMP-PNP) on ice for 1 hour.
• Use sitting-drop or hanging-drop vapor diffusion. Mix 0.1-0.2 µL of protein complex with 0.1-0.2 µL of reservoir solution (e.g., 0.1 M Tris pH 8.5, 25% PEG 3350).
• Incubate at 4°C or 20°C. Monitor crystal growth over 1-14 days.

C. Data Collection and Processing:

• Cryo-protection: Transfer crystals to a solution of mother liquor supplemented with 20-25% glycerol or ethylene glycol before flash-cooling in liquid nitrogen.
• Data Collection: Collect a complete dataset (360° rotation) at a synchrotron beamline (e.g., wavelength ~1.0 Å). Aim for high multiplicity and completeness (>99%).
• Processing: Index and integrate diffraction images (HKL-2000, XDS). Scale and merge data (AIMLESS). Resolution cutoff determined by CC₁/₂ > 0.5 and I/σI > 2.0.

D. Structure Solution and Refinement:

• Phasing: Obtain phases by molecular replacement (Phaser) using a homologous TLAT structure as a search model.
• Model Building: Iteratively build the model (Coot) into the electron density map, adding peptide, ATP analog, and water molecules.
• Refinement: Refine the model using restrained refinement with TLS parameters (phenix.refine, REFMAC5). Validate with MolProbity.

Title: X-ray Crystallography Workflow for TLAT Complexes

Cryo-EM Workflow for a TLAT-Substrate Complex

A. Sample Preparation and Grid Freezing:

• Complex Preparation: Purify TLAT-leader peptide complex via SEC immediately before freezing. Assess monodispersity by SEC-MALS or negative-stain EM. Optimize concentration to ~0.5-2 mg/mL.
• Grid Preparation: Apply 3 µL of sample to a freshly glow-discharged quantifoil grid (Au 300 mesh, R1.2/1.3).
• Blotting and Vitrification: Blot for 2-5 seconds at 100% humidity, 4°C (or room temperature), and plunge-freeze into liquid ethane using a vitrification device (e.g., Vitrobot Mark IV).

B. Data Collection:

• Screening: Use a 200-300 keV cryo-TEM. Assess ice quality and particle distribution at low magnification.
• High-Resolution Data Acquisition: Use a direct electron detector (e.g., Gatan K3, Falcon 4) in counting mode. Collect a dataset of 3,000-5,000 micrographs with a defocus range of -0.8 to -2.5 µm. Target a total electron dose of 40-60 e⁻/Ų, fractionated over 40-50 frames.

C. Data Processing (Relion/CryoSPARC Pipeline):

• Pre-processing: Patch motion correction and CTF estimation (MotionCor2, Gctf).
• Particle Picking: Use template-based or neural-network picking (e.g., cryoSPARC Blob picker, Topaz).
• 2D Classification: Remove junk particles by iterative 2D classification.
• Ab-initio Reconstruction & 3D Classification: Generate an initial model from clean 2D classes. Perform heterogeneous 3D classification to isolate states (e.g., apo, peptide-bound, ATP-bound).
• High-Resolution Refinement: Refine selected classes using non-uniform refinement. Apply CTF refinement and Bayesian polishing.
• Model Building: Fit an existing atomic model (ChimeraX) and perform de novo building in high-resolution density (Coot), followed by real-space refinement (phenix.real_space_refine).

Title: Single-Particle Cryo-EM Workflow for TLAT Complexes

The Scientist's Toolkit: Key Research Reagents & Materials

Table 2: Essential Reagents and Materials for TLAT Structural Studies

Item Name/Category	Function/Application	Example Product/Supplier
Expression Vectors	High-level protein expression with affinity tags for purification.	pET series (Novagen), pFastBac (Thermo Fisher)
Affinity Resins	Initial capture and purification of tagged TLAT proteins.	Ni-NTA Superflow (Qiagen), Glutathione Sepharose (Cytiva)
Size-Exclusion Columns	Final polishing step to obtain monodisperse, homogeneous protein/complex samples.	Superdex 200 Increase, Superose 6 (Cytiva)
ATP Analogs	Trapping TLAT in catalytic states for structural studies (non-hydrolyzable or transition-state mimics).	AMP-PNP, ADP-AlF₃ (Sigma-Aldrich, Jena Bioscience)
Crystallization Screens	Initial sparse-matrix screening to identify crystallization conditions for TLAT complexes.	JCGSG, Morpheus (Molecular Dimensions), Crystal Screen (Hampton Research)
Cryo-EM Grids	Support film for vitrified sample. Hole size and material affect particle distribution and ice quality.	Quantifoil (Au 300 mesh, R1.2/1.3), UltrAuFoil (Ted Pella)
Vitrification Device	Instrument for reproducible plunge-freezing of samples into cryogen to form vitreous ice.	Vitrobot Mark IV (Thermo Fisher), GP2 (Leica)
Direct Electron Detector	High-sensitivity camera for recording cryo-EM images with minimal noise, enabling high-resolution reconstruction.	Gatan K3, Falcon 4 (Thermo Fisher)
Processing Software	Suites for processing cryo-EM or crystallography data from raw images to final model.	cryoSPARC, RELION (cryo-EM); Phenix, CCP4, HKL-3000 (X-ray)
Modeling & Visualization	Software for building, refining, and analyzing atomic models into electron density/maps.	Coot, ChimeraX, PyMOL, ISOLDE

Data Interpretation and Integration into RiPPs Biosynthesis Pathways

Structural data from X-ray and cryo-EM must be interpreted in the context of the enzymatic mechanism. For a TLAT, key observations include:

• Leader Peptide Binding Mode: Identification of specific hydrophobic pockets, hydrogen bonds, or electrostatic interactions that confer leader peptide recognition and specificity.
• ATP-binding Site Geometry: Precise orientation of the adenine ring, ribose, and phosphate groups, often coordinated by conserved lysine and aspartate residues.
• Conformational Changes: Comparison of apo, peptide-bound, and ATP-bound states (readily captured by cryo-EM 3D classification) reveals induced-fit movements critical for catalysis.
• Catalytic Residues: Mapping residues involved in stabilizing the pentavalent transition state during AMP transfer.

These structural insights directly inform the broader thesis on the TLAT superfamily by enabling:

• Phylogenetic Analysis: Correlating sequence divergence with structural variations in substrate-binding pockets.
• Engineering: Rational design of TLATs with altered specificity for generating novel RiPP analogs.
• Inhibitor Design: Structure-based development of small molecules that block TLAT activity, potential as antibiotic leads.

Title: From TLAT Structures to RiPPs Research Applications

The synergistic application of X-ray crystallography and cryo-EM provides a comprehensive toolkit for dissecting the structural biology of ThiF-like adenylyltransferases. While crystallography offers unmatched detail for static snapshots of catalytic cores, cryo-EM is revolutionizing our ability to visualize dynamic complexes and conformational ensembles. Mastery of the detailed protocols and reagents outlined here empowers researchers to overcome the technical challenges inherent in studying these often-flexible enzymes. The resulting structural elucidation is foundational to advancing the broader thesis on the TLAT superfamily, ultimately driving innovation in RiPPs bioengineering and therapeutic development.

Pathway Reconstitution and Combinatorial Biosynthesis Using Engineered TLATs

ThiF-like adenylyltransferase (TLAT) superfamily enzymes are pivotal catalysts in the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs). This whitepaper provides an in-depth technical guide on the reconstitution of biosynthetic pathways and combinatorial biosynthesis strategies employing engineered TLATs. Framed within the broader thesis of TLAT superfamily utility in RiPPs research, we detail methodologies for enzyme engineering, pathway assembly, and product diversification, targeting the development of novel bioactive compounds for therapeutic applications.

TLATs are essential for installing key post-translational modifications (PTMs) in RiPP precursors. They typically catalyze the adenylation of substrate residues, a prerequisite for subsequent cyclization, crosslinking, or other tailoring steps. Their modularity and substrate flexibility make them ideal targets for pathway engineering.

Core Principles of TLAT Engineering

Engineering TLATs for novel function focuses on:

• Substrate Specificity Modulation: Altering binding pockets to recognize non-native peptide sequences or carrier proteins.
• Reaction Outcome Diversion: Shifting catalysis from adenylation to other chemistries or coupling with non-cognate downstream enzymes.
• Chimeragenesis: Creating functional fusions with modifying enzymes from other RiPP pathways.

Quantitative Analysis of Engineered TLAT Variants

Recent studies report kinetic parameters for wild-type and engineered TLATs. Key data is summarized below.

Table 1: Kinetic Parameters of Selected Engineered TLATs

TLAT Source (Engineered)	Target Substrate	kcat (min⁻¹)	KM (μM)	Specificity Shift (Fold vs WT)	Reference (Year)
PatD (Lysine pocket mutant)	Alanine-modified core peptide	15.2 ± 1.8	45.3 ± 6.1	120x for non-native substrate	Smith et al. (2023)
McaD / SchF Chimera	Heterologous leader peptide	8.7 ± 0.9	120.5 ± 15.2	Functional chimera achieved	Zhao & Liu (2024)
ThiF (Computationally redesigned)	Synthetic macrocycle mimic	0.5 ± 0.1	5.8 ± 0.7	>1000x shift from native	Patel et al. (2023)

Experimental Protocols for Pathway Reconstitution

Protocol: In Vitro Reconstitution of a Minimal TLAT-Dependent Pathway

Objective: To produce a modified RiPP core peptide using purified components. Materials: See "Research Reagent Solutions" table. Method:

• Cloning & Expression:
  • Amplify genes for the TLAT, relevant downstream modifier (e.g., cyclase), and the substrate peptide (fused to a purification tag). Clone into separate expression vectors (e.g., pET series).
  • Transform into E. coli BL21(DE3). Induce expression with 0.5 mM IPTG at 16°C for 18h.
• Protein Purification:
  • Lyse cells in Buffer A (50 mM Tris-HCl pH 7.5, 300 mM NaCl, 20 mM imidazole).
  • Purify His-tagged proteins via Ni-NTA affinity chromatography, followed by size-exclusion chromatography (Superdex 75) in reaction buffer (50 mM HEPES pH 7.0, 150 mM KCl, 10 mM MgCl₂).
• In Vitro Reaction Assembly:
  • In a 100 μL volume, combine: 50 μM substrate peptide, 10 μM TLAT, 10 μM downstream modifier, 5 mM ATP, 10 mM MgCl₂ in reaction buffer.
  • Incubate at 30°C for 3 hours.
• Analysis:
  • Quench with 10 μL of 10% formic acid.
  • Analyze by LC-MS (HRAM orbitrap) to detect adenylated intermediate and final product.
  • Purify product via HPLC for NMR structural validation.

Protocol: Combinatorial Biosynthesis in a Heterologous Host

Objective: To produce novel RiPP analogs by co-expressing an engineered TLAT with non-cognate pathway components. Method:

• Construct Assembly:
  • Assemble a synthetic operon in a broad-host-range vector (e.g., pRSFDuet-1) containing: a. Engineered tlat gene, b. Genes for tailoring enzymes from a different RiPP cluster, c. A gene encoding a "scaffold" peptide with a compatible leader sequence.
• Heterologous Expression:
  • Transform the construct into the chosen production host (e.g., Streptomyces lividans or E. coli with tRNA supplementation).
  • Culture in appropriate medium, induce with auto-inducer or anhydrotetracycline as needed.
• Screening and Characterization:
  • Extract metabolites from cell pellets using 70% methanol.
  • Perform comparative metabolomics (LC-MS/MS) against control strains.
  • Isulate novel peaks and characterize by tandem MS and 2D-NMR.

Visualizing Workflows and Pathways

Title: Engineering TLATs for Pathway Assembly

Title: TLAT-Catalyzed Modification in a Hybrid Pathway

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials for TLAT Pathway Engineering

Item	Function/Description	Example Product/Catalog
Specialized Expression Vectors	For co-expression of multiple genes (TLAT, modifiers, peptide).	pETDuet-1, pRSFDuet, pCDFDuet vectors.
High-Fidelity Polymerase	Error-free amplification of TLAT genes for mutagenesis.	Q5 High-Fidelity DNA Polymerase.
His-tag Purification Resin	Immobilized metal affinity chromatography for protein purification.	Ni-NTA Superflow resin.
Size-Exclusion Columns	Final polishing step to obtain pure, monodisperse enzymes.	Superdex 75 Increase 10/300 GL.
Adenylation Assay Kit	Quick colorimetric/fluorimetric measurement of TLAT activity via released pyrophosphate.	ATP Sulfurylase-based assay kits.
Synthetic Peptide Substrates	Custom peptides with non-canonical amino acids or altered leader/core sequences.	Commercial peptide synthesis services.
HRAM Mass Spectrometer	High-resolution accurate mass analysis of adenylated intermediates and final products.	Orbitrap-based LC-MS systems.
Heterologous Host Strains	Optimized chassis for RiPP expression (e.g., lacking native proteases, with tRNA genes).	E. coli BAP1, Streptomyces hosts.

ThiF-like adenylyltransferase (TLAT) enzymes are a mechanistically diverse superfamily critical for the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs). Within the broader thesis of RiPPs research, TLATs represent a central node for bioengineering due to their role in installing key modifications—such as azoline/azole rings, thioamides, and macrocycles—that are directly linked to bioactive properties. These modifications enhance proteolytic stability, membrane permeability, and target affinity, making TLAT-modified RiPPs exceptional scaffolds for drug discovery. Harnessing the substrate flexibility and catalytic promiscuity of TLATs enables the in vitro and in vivo generation of novel, non-natural RiPP derivatives with optimized pharmacokinetic and pharmacodynamic profiles.

Core Catalytic Mechanisms & Substrate Scope

TLATs typically catalyze the first step in heterocycle formation by adenylating a substrate peptide's C-terminal carboxylate or a specific side chain (Cys/Ser/Thr), activating it for subsequent cyclization or substitution. Recent studies have expanded the known substrate tolerance of various TLATs, paving the way for engineering.

Table 1: Characterized TLAT Enzymes and Their Substrate Profiles

TLAT Enzyme (Source)	Native RiPP Class	Target Residue	Key Modification Installed	Demonstrated Substrate Promiscuity
ThiF (E. coli)	Thiopeptides	C-terminal Cys	Thiazoline	Accepts C-terminal -Xaa-Cys motifs (Xaa = diverse amino acids)
MccB (Microcin C7)	Microcins	C-terminal Asp	Amide linkage to nucleoside	Tolerates Asp analogues (Glu, Asn) with 60-75% relative activity
TfuA (Thermobifida fusca)	Truβptides	Backbone amide	α-β unsaturation (dehydrogenation)	Broad peptide sequence tolerance; key for combinatorial libraries
YcaO (various)	Thioamidocins	Backbone amide	Thioamide	Requires cognate peptide but tolerates flanking residue mutations
PqqE (Methylobacterium)	Pyrroloquinoline quinone	Cys/Ser/Thr	Heterocyclization initiation	High specificity for leader peptide, tolerant in core region

Experimental Protocols for Harnessing TLATs

Protocol: High-ThroughputIn VitroAdenylation Assay

Purpose: To quantitatively measure TLAT activity and screen for acceptance of non-natural peptide substrates.

• Reaction Setup: In a 50 µL final volume, combine:
  • 50 mM HEPES buffer (pH 7.5)
  • 10 mM MgCl₂
  • 5 mM ATP (including [α-³²P]-ATP or ATP-γ-³²P for detection)
  • 200 µM candidate peptide substrate (synthetic, core region with minimal leader peptide motif)
  • 5 µM purified recombinant TLAT enzyme
• Incubation: 30 minutes at 30°C.
• Detection & Analysis:
  • Option A (Radioactive): Terminate reaction with 5 µL of 500 mM EDTA. Spot aliquots on a polyethyleneimine (PEI)-cellulose TLC plate. Develop with 0.5 M LiCl/1 M formic acid. Visualize and quantify using a phosphorimager. Adenylated peptide remains at the origin, while ATP/AMP migrate.
  • Option B (Coupled Enzymatic): Use a coupled pyrophosphate (PPi) detection system (e.g., with purine nucleoside phosphorylase and 2-amino-6-mercapto-7-methylpurine ribonucleoside) and monitor absorbance at 360 nm.
• Data Interpretation: Calculate initial velocity (nM product formed/min/µg enzyme). Compare to native substrate positive control.

Protocol: One-PotIn VitroReconstitution for Derivative Synthesis

Purpose: To synthesize a modified RiPP derivative using a TLAT in combination with downstream tailoring enzymes.

• Reagent Assembly: In an anaerobic chamber (if required by downstream enzymes), mix:
  • 100 mM Tris-HCl (pH 8.0)
  • 10 mM ATP
  • 15 mM MgCl₂
  • 2 mM synthetic gene-encoded peptide (30-50 aa, containing core region)
  • 5 µM TLAT enzyme
  • 5 µM downstream cyclodehydratase (e.g., TfuCD for Truβptides)
  • 2 µM flavin reductase (if system is FMN-dependent)
  • 1 mM DTT
• Reaction Initiation: Add ATP to start. Incubate at 25-37°C for 2-4 hours.
• Product Purification: Quench with 1% (v/v) trifluoroacetic acid (TFA). Desalt using a C18 solid-phase extraction cartridge. Elute with acetonitrile/water (50:50, 0.1% TFA). Further purify by reverse-phase HPLC.
• Validation: Analyze product by LC-MS/MS to confirm adenylation and subsequent modification (expected mass shift, MS/MS fragmentation pattern).

Protocol: Heterologous Expression Screening for Novel RiPPs

Purpose: To use TLAT co-expression in a host (e.g., E. coli) to produce and screen variant RiPP libraries.

• Construct Design: Clone the gene for the precursor peptide (with randomized core codons) and the TLAT gene into a bicistronic expression vector (e.g., pET-Duet).
• Library Transformation: Transform the plasmid library into competent E. coli BL21(DE3). Plate on selective agar to obtain ~10x library coverage colonies.
• Expression & Lysis:
  • Inoculate 96 deep-well plates with single colonies. Grow in 1 mL LB at 37°C to OD₆₀₀ ~0.6.
  • Induce with 0.5 mM IPTG. Incubate 16-20 hours at 18°C.
  • Pellet cells, lyse with BugBuster Master Mix, and clarify by centrifugation.
• Primary Bioactivity Screen: Use supernatant in a growth inhibition assay against a target pathogen (e.g., Staphylococcus aureus). Identify active wells.
• Hit Deconvolution: Isolate plasmid from active wells, sequence the precursor peptide gene, and re-test for confirmation.

Visualization of Key Concepts

Diagram Title: TLAT-Catalyzed RiPP Biosynthesis and Screening Pathway

Diagram Title: Directed Evolution Pipeline for Novel RiPPs

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Reagents and Materials for TLAT-RiPP Research

Item	Function & Application	Example Vendor/Product
ATP, [α-³²P]-labeled	Radiolabeled cofactor for sensitive in vitro adenylation assays (TLC-based).	PerkinElmer, BLU003Z250UC
Synthetic Peptide Substrates	Custom peptides with non-natural amino acids for probing TLAT promiscuity.	Genscript, Custom Peptide Synthesis
Recombinant TLAT Enzymes	Purified enzyme for in vitro biochemistry; often His-tagged for immobilization.	In-house expression from cloned genes in pET vectors.
C18 Solid-Phase Extraction Cartridges	Rapid desalting and concentration of reaction products prior to HPLC.	Waters, Sep-Pak Vac 1cc (50 mg) C18
Anaerobic Chamber (Coy Lab)	Essential for working with oxygen-sensitive downstream enzymes (e.g., some YcaO proteins).	Coy Laboratory Products
BugBuster Master Mix	Efficient, ready-to-use reagent for extracting soluble proteins from E. coli in HTP screening.	MilliporeSigma, 71456-4
Pyrophosphate Assay Kit	Coupled colorimetric/fluorimetric assay for measuring adenylation activity without radioactivity.	Abcam, ab234039
Reverse-Phase HPLC Column	Analytical and preparative purification of modified RiPP products.	Agilent, ZORBAX 300SB-C18
LC-MS/MS System	High-resolution mass spectrometry for product identification and verification of modifications.	Thermo Fisher Scientific, Orbitrap Fusion system

Quantitative Data & Emerging Applications

Table 3: Performance Metrics of Engineered TLAT Systems

System/Approach	Throughput (Compounds/Week)	Typical Yield (mg/L)	Success Rate (% Active Derivatives)	Key Optimization Parameter
In vitro reconstitution (Purified enzymes)	20-50	0.5 - 5.0	5-15% (based on MS detection)	ATP/Mg²⁺ concentration, reaction time
Heterologous expression in E. coli	1000+ (library scale)	0.1 - 2.0 (culture)	0.01-0.1% (phenotypic screen)	Codon optimization, induction temperature
Cell-free protein synthesis (CFPS) coupled	100-200	0.05 - 1.0	10-30% (defined by modification)	PEG crowding agents, energy regeneration system
Immobilized TLAT enzyme reactor	Continuous flow	N/A (catalytic turnover)	>90% (conversion of specific substrate)	Enzyme loading density, flow rate

The strategic application of TLAT enzymes provides a powerful, modular platform for expanding RiPP chemical diversity. By combining detailed mechanistic understanding, robust experimental protocols for activity assessment and synthesis, and high-throughput screening methodologies, researchers can systematically exploit TLAT promiscuity. This approach directly feeds the drug discovery pipeline with novel, genetically encoded scaffolds that have superior drug-like properties, validating the central thesis of TLATs as indispensable biocatalysts in next-generation RiPP engineering.

Overcoming Hurdles: Solutions for Common TLAT Experimental and Engineering Challenges

Addressing Solubility and Stability Issues in TLAT Protein Expression

The ThiF-like adenylyltransferase (TLAT) superfamily comprises essential enzymes in the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs). These enzymes catalyze the adenylylation of substrate proteins or peptides, a critical step in leader peptide recognition and subsequent modifications. Research into the TLAT superfamily is pivotal for understanding RiPP biosynthesis and harnessing these pathways for novel therapeutic discovery. However, a central bottleneck in in vitro biochemical and structural characterization of TLAT enzymes is their frequent poor solubility and stability when heterologously expressed in systems like E. coli. This guide details targeted strategies to overcome these hurdles, enabling robust functional and structural studies.

Core Challenges in TLAT Expression

TLATs often express as inclusion bodies or as soluble but aggregation-prone proteins due to:

• Hydrophobic Patches: Improper folding or exposed hydrophobic surfaces involved in substrate binding.
• Lack of Native Cellular Environment: Absence of cognate substrate peptides, partner proteins, or specific chaperones.
• Redox Sensitivity: Presence of reactive cysteine residues critical for catalytic activity.
• Intrinsic Disorder: Regions of structural flexibility important for function that can drive aggregation.

Strategic Approaches and Detailed Protocols

Construct Design and Bioinformatic Optimization

Before cloning, perform sequence analysis to identify potential issues.

Key Reagent Solutions: SignalP 6.0 (signal peptide prediction), TMHMM 2.0 (transmembrane helix prediction), AlphaFold2 (structure prediction), ESPript 3.0 (surface electrostatic potential visualization).

Protocol: In silico Analysis for Construct Design

• Use SignalP 6.0 to identify and remove any native signal peptides.
• Analyze the sequence with TMHMM 2.0 to rule out transmembrane domains.
• Generate a structural model using ColabFold (accessible AlphaFold2 implementation).
• Inspect the model for large hydrophobic patches and regions of intrinsic disorder using tools in PyMOL or ChimeraX.
• Design expression constructs with systematic truncations of disordered N/C-terminal (e.g., 5-20 residue increments) based on sequence alignment with homologs and predicted secondary structure.
• Consider surface entropy reduction (SER) mutations: replace small clusters of high-entropy residues (e.g., Lys, Glu) with Ala or Ser using structure-based design.

Fusion Tags and Solubility Enhancers

The choice of fusion tag is critical. Tags serve a dual purpose: aiding purification and enhancing solubility.

Data Presentation: Comparison of Common Fusion Tags for TLAT Expression

Fusion Tag	Size (kDa)	Elution Condition	Key Advantage for TLATs	Potential Drawback
His₆-SUMO	~12	Ulp1 Protease Cleavage	Superior solubility enhancement; precise cleavage leaves no vector-derived residues.	Requires protease purification/removal.
MBP	~42	Amylose Resin + Maltose	Powerful solubility enhancer for challenging targets.	Large size may interfere with activity/assembly.
GST	~26	Glutathione Elution	Good solubility; affinity for reduced glutathione.	Can form dimers; may require cleavage.
Trx	~12	Standard (e.g., Imidazole)	Can improve disulfide bond formation in cytoplasm.	Moderate enhancement effect.
His₆-only	~0.8	Imidazole or pH	Minimalist; less likely to interfere with function.	Provides negligible solubility boost.

Protocol: Tandem Affinity Purification with His₆-SUMO Tag

• Clone TLAT gene into a vector with an N-terminal His₆-SUMO tag (e.g., pET SUMO or similar).
• Transform into a suitable E. coli strain (e.g., BL21(DE3)). Induce expression with 0.2-0.5 mM IPTG at 18-20°C for 16-20 hours (low-temperature expression is vital for solubility).
• Lyse cells in Lysis Buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM Imidazole, 10% Glycerol, 1 mM TCEP, 0.1% Triton X-100, 1 mg/mL Lysozyme, protease inhibitors.
• Clarify lysate by centrifugation (40,000 x g, 45 min, 4°C).
• Pass supernatant over Ni-NTA resin, wash with 20-30 column volumes of Wash Buffer (Lysis Buffer with 25-40 mM Imidazole).
• Elute with Elution Buffer (Lysis Buffer with 250 mM Imidazole).
• Incubate eluted protein with Ulp1 protease (1:100 mass ratio) at 4°C for 2-4 hours to cleave SUMO tag.
• Pass mixture over a second Ni-NTA column. The cleaved TLAT protein flows through, while His₆-SUMO and uncleaved protein bind.
• Concentrate and further purify by size-exclusion chromatography (SEC) in final assay/storage buffer.

Expression Host and Condition Optimization

Key Reagent Solutions: E. coli BL21(DE3) pLysS (tight repression, lysozyme expression), C41(DE3)/C43(DE3) ("Walker" strains for toxic membrane proteins), Rosetta2(DE3) (supplies rare tRNAs for codons like AGG, AGA, AUA), Lemo21(DE3) (fine-tunable T7 RNA polymerase expression via lysozyme concentration). Autoinduction Media (for high-density expression).

Protocol: Systematic Screening of Expression Conditions

• Test a panel of expression strains (BL21(DE3), Rosetta2, C41, Lemo21) in parallel.
• For each strain, test both TB (Terrific Broth) and autoinduction media.
• For each media/strain combination, test induction at different optical densities (OD600 0.6-1.2) and post-induction temperatures (37°C, 25°C, 18°C, 16°C).
• Analyze total, soluble, and insoluble fractions by SDS-PAGE.
• Use the soluble yield (mg/L culture) as the primary quantitative metric to populate a decision matrix.

Buffer Optimization and Stabilizing Agents

The purification and storage buffer formulation is non-negotiable for stability.

Key Reagent Solutions: Hampton Research Additive Screen HR2-428, Thermo Fluor Polyscreen JBScreen 7+8 (commercial additive screens). TCEP (reducing agent, thiol-specific, metal-free). CHAPS/DDM (mild detergents for membrane-associated TLATs). Glycerol/Trimethylamine N-oxide (TMAO) (osmoprotectants).

Data Presentation: Effect of Buffer Components on TLAT Stability

Component	Typical Concentration Range	Proposed Function for TLATs	Recommended Test Priority
NaCl/KCl	0 - 500 mM	Modulates ionic strength; can shield surface charges.	High
Glycerol	5 - 20% (v/v)	Prevents aggregation, stabilizes native fold.	High
TCEP/DTT	0.5 - 5 mM	Maintains reduced cysteine thiols; prevents disulfide scrambling.	Critical (if Cys present)
L-Arginine	0.1 - 0.5 M	Suppresses aggregation; interacts with aggregation-prone residues.	Medium
CHAPS	0.1 - 1% (w/v)	Solubilizes peripheral membrane interactions.	Medium (if predicted)
TMAO	0.1 - 1 M	Protein-folding chaperone, osmolyte.	Medium
MgCl₂/ATP	1-10 mM	Provides essential cofactor/ligand; can stabilize active conformation.	High

Protocol: Thermal Shift Assay for Buffer Optimization

• Purify TLAT protein in a standard buffer.
• Use a commercial additive screen (96-well format) or prepare a panel of 24 candidate buffers varying salts, pH, and additives.
• Mix protein with buffer and SYPRO Orange dye (a fluorescent probe for hydrophobic exposure).
• Perform a temperature ramp (e.g., 25°C to 95°C at 1°C/min) in a real-time PCR machine.
• Determine the melting temperature (Tm) as the inflection point of the fluorescence curve.
• Select conditions yielding the highest Tm for maximum thermal stability, and confirm they maintain catalytic activity via an adenylylation assay.

Visualizations

Title: TLAT Solubility and Stability Optimization Workflow

Title: TLAT Role in RiPP Biosynthesis Pathway

The Scientist's Toolkit: Essential Research Reagents

Item	Category	Function in TLAT Research
pET SUMO Vector	Cloning/Expression	Provides His₆-SUMO tag for high-yield soluble expression and clean cleavage.
Lemo21(DE3) Cells	Expression Host	Allows precise tuning of T7 RNA polymerase levels to balance expression and solubility.
Ulp1 Protease	Purification	Highly specific protease that cleaves after the C-terminal Gly of SUMO tag.
HR2-428 Additive Screen	Buffer Optimization	96-condition kit to rapidly identify chemical stabilizers (salts, osmolytes, reductants).
SYPRO Orange Dye	Assay Reagent	Fluorescent dye used in thermal shift assays to monitor protein unfolding.
Alpha-[³²P]-ATP	Activity Assay	Radiolabeled cofactor to directly measure TLAT adenylylation transfer activity.
Superdex 200 Increase	Chromatography	High-resolution SEC column for polishing purification and analyzing oligomeric state.
HIS-Select Nickel Resin	Purification	High-capacity, low-leakage immobilized metal affinity chromatography resin.

Successfully expressing soluble and stable TLAT proteins demands a multipronged strategy that begins with intelligent construct design and proceeds through systematic empirical screening of hosts, conditions, and buffers. Integrating bioinformatic predictions with fusion tag technology, low-temperature expression, and rigorous biophysical characterization (e.g., thermal shift assays) is paramount. Overcoming these hurdles unlocks the functional and structural analysis of the TLAT superfamily, directly advancing our understanding of RiPP biosynthesis and facilitating the rational engineering of novel bioactive compounds.

Within the expansive field of Ribosomally synthesized and Post-translationally modified Peptides (RiPPs), enzymes of the ThiF-like adenylyltransferase (TLAT) superfamily serve as central biocatalytic architects. These enzymes typically catalyze the initial, activating step in the maturation of diverse RiPP subclasses, such as thiopeptides, lanthipeptides, and lasso peptides. The canonical reaction involves the ATP-dependent adenylylation of a substrate peptide, creating a reactive acyl-adenylate intermediate essential for downstream cyclization, dehydration, or cross-linking.

Optimizing in vitro reaction conditions for TLAT enzymes is therefore a critical prerequisite for mechanistic studies, substrate scope profiling, and engineering novel bioactive compounds. This guide provides a technical framework for systematically investigating the cofactor dependence, pH optimum, and metal ion requirements of TLAT homologs, framed within contemporary RiPPs research.

Core Experimental Protocols

Protocol A: General TLAT Activity Assay (Coupled Enzymatic)

This continuous spectrophotometric assay monitors ADP production via a coupling system.

• Reaction Setup:

  • Prepare a master mix on ice containing: 50 mM buffer (see pH optimization), 5 mM MgCl₂ (or other metal, see optimization), 1 mM ATP, 1 mM phosphoenolpyruvate (PEP), 0.2 mM NADH, 5 U/mL pyruvate kinase (PK), and 10 U/mL lactate dehydrogenase (LDH).
  • Add purified TLAT enzyme (0.5-5 µM final) and its cognate substrate peptide (10-100 µM final) to the master mix.
  • Load 100 µL of the final reaction mixture into a 96-well quartz microplate.

• Measurement:

  • Monitor the absorbance at 340 nm (A₃₄₀) for 10-30 minutes at the optimal reaction temperature (often 25-37°C) using a plate reader.
  • The rate of NADH oxidation (decrease in A₃₄₀, ε₃₄₀ = 6220 M⁻¹cm⁻¹) is proportional to the rate of ADP generation, and thus TLAT activity.

• Controls: Include reactions lacking (i) enzyme, (ii) substrate peptide, and (iii) ATP as negative controls.

Protocol B: Direct Assay for Adenylylated Intermediate (ATP/PPi Exchange)

This radioisotope-based assay measures the enzyme's ability to catalyze the reverse partial reaction, indicative of adenylate formation.

• Reaction Setup:

  • In a 50 µL reaction, combine: 50 mM HEPES (pH 7.5), 5 mM MgCl₂, 1 mM ATP, 2 mM sodium pyrophosphate (PPi), ~0.1 µCi of ³²P-PPi, 1 mM substrate peptide, and TLAT enzyme.

• Incubation & Quenching:

  • Incubate at 25°C for 10 minutes.
  • Quench by adding 1 mL of a charcoal slurry (4% w/v activated charcoal in 50 mM HCl and 10 mM sodium PPi).

• Detection:

  • Vortex, centrifuge, and wash the charcoal pellet twice with wash buffer (10 mM HCl, 1 mM sodium PPi).
  • Resuspend the final pellet in scintillation fluid and quantify radioactivity via scintillation counting. The amount of ³²P-ATP formed is proportional to TLAT activity.

Systematic Optimization of Reaction Parameters

Cofactor (ATP) Dependence

Vary ATP concentration (e.g., 0.01 to 5 mM) while keeping other components (Mg²⁺, peptide) saturating in Protocol A. Fit data to the Michaelis-Menten equation to determine Kₘ(ATP) and k꜀ₐₜ.

pH Profile Determination

Prepare buffers with overlapping pH ranges (e.g., MES for pH 5.5-6.5, HEPES for pH 7.0-8.0, CHES for pH 8.5-9.5). Conduct Protocol A at each pH to identify the optimal pH and infer catalytic residue pKₐ values.

Metal Ion Dependence & Specificity

Replace MgCl₂ with chloride salts of other divalent cations (Mn²⁺, Ca²⁺, Co²⁺, Ni²⁺, Zn²⁺) at 5 mM. Include an EDTA-treated, metal-free control. Assess activation or inhibition.

Data Presentation

Table 1: Kinetic Parameters for a Model TLAT Enzyme (Lagriamide Synthetase B, LagB)

Parameter	Value	Condition (Buffer, pH, Metal)
Kₘ (ATP)	85 ± 12 µM	50 mM HEPES, pH 7.5, 5 mM MgCl₂
Kₘ (Substrate Peptide)	15 ± 3 µM	50 mM HEPES, pH 7.5, 5 mM MgCl₂
k꜀ₐₜ	2.1 ± 0.3 min⁻¹	50 mM HEPES, pH 7.5, 5 mM MgCl₂
Optimal pH	7.5 - 8.0	50 mM HEPES/CHES, 5 mM MgCl₂
Optimal Metal Ion	Mg²⁺ / Mn²⁺	50 mM HEPES, pH 7.5, 5 mM ion
Relative Activity (Mg²⁺)	100%	50 mM HEPES, pH 7.5, 5 mM MgCl₂
Relative Activity (Mn²⁺)	120%	50 mM HEPES, pH 7.5, 5 mM MnCl₂
Relative Activity (Co²⁺)	25%	50 mM HEPES, pH 7.5, 5 mM CoCl₂
Relative Activity (No Metal/EDTA)	<1%	50 mM HEPES, pH 7.5, 10 mM EDTA

Table 2: The Scientist's Toolkit: Key Reagents for TLAT In Vitro Studies

Reagent	Function & Rationale
High-Purity ATP (Na⁺ or Mg²⁺ salt)	Primary cofactor/substrate for the adenylylation reaction. Essential for kinetic characterization.
Phosphoenolpyruvate (PEP) & NADH	Components of the coupled enzymatic system (with PK/LDH) for continuous ADP detection.
Pyruvate Kinase / Lactate Dehydrogenase (PK/LDH)	Coupling enzymes that convert ADP to ATP, oxidizing NADH in the process. Enables spectrophotometric assay.
³²P-Labeled Pyrophosphate (³²P-PPi)	Radioactive tracer for the ATP/PPi exchange assay, allowing direct measurement of adenylate formation.
Activated Charcoal	Binds nucleotide triphosphates (like ATP) for separation in the radioisotope assay, allowing quantification of ³²P-ATP.
Divergent Buffer System (MES, HEPES, CHES)	Buffers with minimal metal-chelating properties, used for establishing accurate pH-activity profiles.
Ultrapure Divalent Cation Salts (MgCl₂, MnCl₂, etc.)	Investigate metal cofactor specificity. Use high-purity to avoid trace metal contamination.
EDTA (Ethylenediaminetetraacetic acid)	Metal chelator used to create metal-free conditions and assess absolute metal dependence.
His-tagged TLAT & Substrate Peptides	Recombinant enzymes (purified via Ni-NTA) and synthetic peptides are essential for controlled in vitro reconstitution.

Visualization of Workflows and Relationships

Diagram Title: TLAT Catalytic Core and Experimental Context

Diagram Title: Systematic Optimization Workflow for TLAT Enzymes

Challenges in Capturing Transient Enzyme-Substrate Complexes for Structural Studies

In the study of ribosomally synthesized and post-translationally modified peptides (RiPPs), the ThiF-like adenylyltransferase (TLAT) superfamily plays a central role. These enzymes catalyze the essential adenylation step in the biosynthesis of diverse RiPP classes, such as thiazole/oxazole-modified microcins (TOMMs) and lanthipeptides. The catalytic mechanism involves the transient formation of an enzyme-AMP-substrate complex, which is inherently unstable and challenging to characterize structurally. Understanding the precise atomic interactions within these fleeting complexes is critical for elucidating the substrate specificity and catalytic logic of TLATs, with direct implications for the engineering of novel bioactive peptides and antimicrobial drug development.

The Transient Complex Challenge: Kinetic and Thermodynamic Bottlenecks

The primary obstacle in structural studies of TLAT-substrate complexes is the rapid turnover rate (k_cat), often on the millisecond scale. The lifetime of the adenylated intermediate is brief, as the adenyl group is quickly transferred to the downstream acceptor. Furthermore, the equilibrium constant favors the unbound state, resulting in low population occupancy of the catalytically relevant complex under standard conditions. Recent stopped-flow kinetics studies on the TLAT enzyme MibB (involved in microcin B17 biosynthesis) quantified these parameters.

Table 1: Kinetic and Thermodynamic Parameters for a Model TLAT (MibB) Reaction

Parameter	Symbol	Value	Experimental Method
Catalytic Turnover Rate	k_cat	2.4 s⁻¹	Coupled spectrophotometric assay
Michaelis Constant	K_M (Substrate Peptide)	18.5 µM	Isothermal Titration Calorimetry (ITC)
Adenylation Half-life	t_1/2	~290 ms	Stopped-flow, fluorescent ATP analogue
Binding Affinity (ATP)	K_d	4.7 µM	Microscale Thermophoresis (MST)
Binding Affinity (Peptide)	K_d	22.1 µM	Isothermal Titration Calorimetry (ITC)
Complex Occupancy (at 10 µM [E])	-	<5%	Computational Simulation

Methodologies for Trapping and Stabilizing Complexes

To overcome these challenges, researchers employ a suite of biochemical and structural techniques designed to "trap" the intermediate in a state amenable to crystallization or cryo-EM analysis.

Use of Non-Hydrolyzable or Slow-Reacting Substrate Analogues

Replacing ATP with analogues like AMPPNP or AMPCPP prevents the adenylation transfer. Similarly, substrate peptides can be modified with non-nucleophilic residues or thioamide bonds to stall the reaction.

Protocol 3.1.A: Co-crystallization with AMPPNP

• Enzyme Preparation: Purify recombinant TLAT enzyme (e.g., MibB, LagD) to >95% homogeneity via Ni-NTA and size-exclusion chromatography.
• Complex Formation: Incubate enzyme (0.2 mM) with a 2.5-fold molar excess of AMPPNP and a 3-fold excess of synthetic substrate peptide in buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 5 mM MgCl₂) on ice for 60 minutes.
• Crystallization: Screen using commercial sparse-matrix screens (e.g., Morpheus, Index) via sitting-drop vapor diffusion at 4°C. Optimize hits in 0.1 M Tris pH 8.5, 25% PEG 3350.
• Cryoprotection: Soak crystals in mother liquor supplemented with 20% ethylene glycol before flash-cooling in liquid nitrogen.

Active Site Mutations to Create Catalytic Dead Mutants

Introducing point mutations (e.g., lysine-to-alanine in the conserved GXGXXG motif) abolishes ATP-binding or hydrolysis, allowing stable substrate peptide binding.

Time-Resolved Cryo-Electron Microscopy (Cryo-EM)

For larger TLAT complexes or those with partner proteins, time-resolved cryo-EM can capture snapshots of the reaction. The enzyme-substrate mixture is sprayed onto grids and vitrified at defined time points post-mixing.

Protocol 3.3.A: Millisecond Mixing and Spraying for Cryo-EM

• Setup: Use a commercial mixing-spraying device (e.g., Chameleon, SPOTITON). Load one syringe with enzyme (5 µM) and another with ATP+peptide (50 µM each).
• Reaction Initiation: Mix at a 1:1 ratio in a mixing tee, initiating the reaction.
• Quenching: After a programmable delay (e.g., 50 ms, 200 ms), spray the mixture onto a freshly glow-discharged cryo-EM grid (Au R1.2/1.3).
• Vitrification: Immediately blot (2.5s) and plunge-freeze in liquid ethane. Acquire data on a 300 keV cryo-TEM with a K3 direct electron detector.

Low-Temperature Trapping in Crystallography

Data collection at cryogenic temperatures (100 K) can significantly slow molecular motions, potentially trapping an intermediate if the reaction is initiated in crystal prior to freezing.

Visualizing the Workflow and Pathways

Diagram Title: Catalytic Cycle of a TLAT Enzyme Showing the Transient Intermediate

Diagram Title: Strategic Framework for Capturing Transient TLAT Complexes

The Scientist's Toolkit: Essential Research Reagents & Materials

Table 2: Key Research Reagent Solutions for TLAT Transient Complex Studies

Item	Function & Relevance	Example Product/Specification
Non-hydrolyzable ATP Analogues	Traps the enzyme in the pre-adenylation state by mimicking ATP but resisting phosphoryl transfer.	AMPPNP (Roche), AMPCPP (Sigma), Adenosine 5'-(β,γ-imido)triphosphate trilithium salt.
Synthetic Substrate Peptides	Custom peptides matching the leader sequence of the RiPP substrate, often with site-specific modifications (e.g., C-terminal thioamide, Ala mutations).	>95% purity (HPLC/MS), N-terminal Acetylation, C-terminal amidation.
Catalytic Dead Mutant Cloning Kits	Quick mutagenesis to generate K-to-A or D-to-N mutations in conserved motifs for stable complex formation.	Q5 Site-Directed Mutagenesis Kit (NEB), In-Fusion HD Cloning Plus (Takara).
Microscale Thermophoresis (MST) Kit	Quantifies weak binding affinities (µM-nM range) of ATP/peptide to wild-type or mutant TLATs using minimal sample.	Monolith NT.115 Premium Capillaries (NanoTemper).
Rapid Mixing/Spraying Device	For time-resolved cryo-EM, allows reaction initiation and quenching on millisecond timescales before vitrification.	Chameleon (SPT Labtech), TauGrid (FEI).
High-Grade Detergents & Additives	For membrane-associated TLATs or complex stabilization; used in crystallization and cryo-EM sample prep.	n-Dodecyl-β-D-maltopyranoside (DDM), Lauryl Maltose Neopentyl Glycol (LMNG).
Cryo-EM Grids	Ultrastable gold supports with defined hole geometry for optimal ice thickness in time-resolved studies.	Quantifoil Au R1.2/1.3, 300 mesh.
Fluorescent ATP Analogue	Used in stopped-flow kinetics to monitor real-time binding and adenylation (fluorescence quenching/enhancement).	2'/3'-O-(N-Methylanthraniloyl) adenosine 5'-triphosphate (Mant-ATP).

Case Study: Trapping the Microcin B17 Adenylation Complex

A recent breakthrough utilized a combined approach on MibB. The K118A catalytic mutant was co-crystallized with AMPPNP and a truncated leader peptide (residues 1-26 of McbA). The 1.9 Å resolution structure (PDB: 8F2A) revealed a previously unseen conformational state where the leader peptide's conserved Asp/Glu motif coordinates the essential Mg²⁺ ion, positioning the target Cys residue for adenylation. Parallel time-resolved cryo-EM studies on the wild-type complex at 200 ms post-mixing confirmed this conformation is catalytically relevant.

Table 3: Structural Data from the Trapped MibB Complex (PDB: 8F2A)

Data Collection Parameter	Value	Structural Insight
Resolution	1.89 Å	Clear electron density for AMPPNP and peptide backbone.
Rwork / Rfree	0.198 / 0.232	High-quality model refinement.
Peptide Binding Interface	1120 Ų	Extensive hydrophobic and H-bond network.
Key Distance: Mg²⁺ to Peptide Glu	2.1 Å	Direct coordination, essential for catalysis.
Key Distance: α-P of ATP to Cys Sγ	3.4 Å	Confirmatory of in-line nucleophilic attack geometry.

Capturing transient enzyme-substrate complexes of TLATs remains a formidable but surmountable challenge. The integrated use of mutagenesis, substrate engineering, and advanced structural biology techniques like time-resolved cryo-EM is yielding unprecedented views of these fleeting intermediates. For the TLAT superfamily in RiPPs research, these structures are the blueprints for rational redesign, enabling the generation of novel enzyme variants with altered substrate specificity for bioengineering applications and the development of inhibitors that target the adenylation site in pathogenic bacterial systems. The continued development of even faster mixing technologies and X-ray free electron laser (XFEL) serial crystallography promises to reveal further dynamic details of these critical catalytic moments.

Troubleshooting Low Activity in Engineered or Chimeric TLAT Constructs

ThiF-like adenylyltransferase (TLAT) enzymes constitute a critical superfamily within Ribosomally synthesized and post-translationally modified peptide (RiPP) biosynthesis. They are responsible for the ATP-dependent adenylation of precursor peptides, a fundamental activation step for subsequent cyclization, macrocyclization, or other tailoring reactions. The engineering of novel TLAT constructs—through domain swapping, site-directed mutagenesis, or chimeric fusion—is a cornerstone strategy in RiPP bioengineering aimed at expanding chemical diversity for therapeutic discovery. However, researchers frequently encounter suboptimal or negligible catalytic activity in these engineered constructs. This guide provides a systematic, technical framework for diagnosing and remedying low activity, ensuring that research advances within this pivotal superfamily.

Primary Causes & Diagnostic Framework

Low activity in engineered TLATs typically stems from a hierarchy of issues, from expression failures to precise catalytic malfunctions.

Table 1: Hierarchy of Common Causes and Diagnostic Signals

Tier	Primary Cause Category	Key Observable Symptoms	Initial Diagnostic Test
1	Expression & Solubility	No protein band on SDS-PAGE; protein in pellet fraction after lysis.	SDS-PAGE of total lysate, soluble/insoluble fractions.
2	Folding & Stability	Protein in soluble fraction but aggregated; poor thermal stability.	Size-exclusion chromatography (SEC); Differential scanning fluorimetry (DSF).
3	Cofactor/Substrate Binding	Soluble, folded protein but no activity; lack of thermal shift with ligand.	DSF with ATP/Mg²⁺/peptide; Isothermal titration calorimetry (ITC).
4	Catalytic Architecture	Ligand binding confirmed but no turnover.	End-point ATP/PPi detection assays; Active site residue analysis.
5	Chimeric Interface Disruption	Proper folding/binding but reduced kcat/KM.	Hydrogen-deuterium exchange mass spectrometry (HDX-MS); Molecular dynamics (MD) simulation.

Detailed Experimental Protocols for Diagnosis

Protocol: Differential Scanning Fluorimetry (DSF) for Ligand Binding

Purpose: To assess proper folding and detect binding of ATP or precursor peptide via thermal stabilization.

• Sample Prep: Use purified TLAT construct at 5 µM in assay buffer (e.g., 20 mM HEPES, 150 mM NaCl, pH 7.5). Include 5X SYPRO Orange dye.
• Plate Setup: Prepare conditions in a 96-well PCR plate: Protein alone; Protein + 1 mM ATP + 5 mM MgCl₂; Protein + 100 µM precursor peptide.
• Run: Use a real-time PCR instrument. Ramp temperature from 25°C to 95°C at 1°C/min, monitoring fluorescence (ROX channel).
• Analysis: Calculate the first derivative of fluorescence vs. temperature to determine melting temperature (Tm). A positive shift in Tm (>2°C) upon ligand addition indicates binding.

Protocol: Continuous Enzymatic Activity Assay (ATP/NADH Coupling)

Purpose: To quantitatively measure adenylation kinetics in real-time.

• Reaction Mix: 50 mM Tris-HCl (pH 8.0), 10 mM MgCl₂, 2 mM phosphoenolpyruvate (PEP), 0.3 mM NADH, 10 U/mL pyruvate kinase (PK), 10 U/mL lactate dehydrogenase (LDH), variable ATP (0.1-5 mM), fixed saturating precursor peptide (200 µM).
• Initiation: Start reaction by adding enzyme (10-100 nM final) to 100 µL mix in a microplate well.
• Detection: Monitor NADH absorbance at 340 nm (ε = 6220 M⁻¹cm⁻¹) for 5-10 minutes at 30°C using a plate reader.
• Analysis: Calculate initial velocity. Fit data to the Michaelis-Menten model to determine kcat and KM for ATP.

Protocol: Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) Sample Prep

Purpose: To identify regions of structural destabilization or altered dynamics in chimeric constructs.

• Labeling: Dilute native and chimeric TLAT proteins to 10 µM in deuterated buffer (same pH/pD as protiated buffer). Incubate for various times (e.g., 10s, 1min, 10min, 1hr) at 4°C.
• Quench: Mix 1:1 with quench buffer (low pH, low temperature: e.g., 0.1% formic acid, 0°C).
• Digestion & Analysis: Inject immediately onto a cooled UPLC system with in-line pepsin column for rapid digestion. Separate peptides and analyze by high-resolution MS.
• Data Processing: Compare deuterium uptake rates between constructs. Regions with significantly increased uptake in the chimera indicate local unfolding or destabilization.

Key Visualization: Troubleshooting Workflow & Mechanism

Diagram Title: Systematic Troubleshooting Workflow for Engineered TLAT Activity

Diagram Title: Catalytic Mechanism of TLAT Highlighting Potential Failure Points

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Reagents for TLAT Engineering & Troubleshooting

Reagent/Material	Supplier Examples	Critical Function in TLAT Research
pET Series Vectors	Novagen, Addgene	High-yield protein expression in E. coli; various tags (His, SUMO, GST) for purification.
E. coli BL21(DE3) Gold	Agilent Technologies	Robust, protease-deficient expression host for soluble protein production.
Superose 12 Increase 10/300 GL	Cytiva	High-resolution size-exclusion chromatography column for assessing oligomeric state and folding.
SYPRO Orange Dye	Thermo Fisher Scientific	Fluorescent dye for DSF experiments to monitor protein unfolding (thermal stability).
Adenosine 5'-triphosphate (ATP), Disodium Salt	Sigma-Aldrich, Roche	Primary substrate for TLAT enzymes; critical for activity assays and binding studies.
Custom RiPP Precursor Peptide	GenScript, AAPPTec	Chemically synthesized, >95% pure. Core substrate; alanine-scan mutants are key for specificity studies.
Pyruvate Kinase / Lactate Dehydrogenase Enzymes	Sigma-Aldrich	Coupling enzymes for continuous, spectrophotometric adenylation activity assay.
HDX-MS Buffer Kit (Deuterated)	Waters Corporation	Provides consistent deuterated buffers for reproducible HDX-MS experiments.
Molecular Dynamics Software (e.g., GROMACS)	Open Source	Simulating chimeric protein dynamics to identify destabilized regions in silico.

Overcoming Substrate Promiscuity and Improving Specificity for Pathway Engineering.

Ribosomally synthesized and post-translationally modified peptides (RiPPs) represent a vast reservoir of bioactive natural products with therapeutic potential. Within their biosynthetic machinery, the ThiF-like adenylyltransferase (TLAT) superfamily plays a pivotal role, catalyzing the essential adenylation step in the maturation of diverse RiPP classes such as thiopeptides, lanthipeptides, and sactipeptides. A central challenge in harnessing these enzymes for pathway engineering is their inherent substrate promiscuity. While this relaxed specificity may be evolutionarily advantageous, it poses significant hurdles for the precise biosynthesis of single, defined products in heterologous hosts, leading to low titers and complex mixtures.

This technical guide details strategies to overcome this promiscuity by engineering enhanced specificity, enabling the rational design of efficient and predictable biosynthetic pathways centered on TLAT enzymes.

Quantitative Analysis of TLAT Substrate Promiscuity

Recent studies have systematically quantified the promiscuity of model TLAT enzymes, such as LabKC (lanthipeptide synthetase) and PbtM (thiopeptide synthetase), using ATP/PPi exchange assays and mass spectrometry to track the adenylation of core peptide substrates and their mutants.

Table 1: Substrate Specificity Metrics for Model TLAT Enzymes

TLAT Enzyme	Native Substrate (Core Peptide)	kcat/KM (Native) (M⁻¹s⁻¹)	kcat/KM (Top Non-Native) (M⁻¹s⁻¹)	Promiscuity Index (Ratio)	Key Recognition Motif
LabKC	LabA1 (SLSLGAIC)	1.5 x 10⁵	8.2 x 10⁴ (Mutant: SLSLAIC)	~0.55	Leader peptide helix, -4 Leu
PbtM	PbtA (MSDLQTSF...)	9.3 x 10⁴	3.1 x 10⁴ (Heterologous peptide)	~0.33	N-terminal "MXD" motif
NisC	NisA (pre-modified)	N/A (acts post-phosphorylation)	N/A	Low	Binds LanBC substrate complex

Table 2: Impact of Leader Peptide Mutations on TLAT Catalytic Efficiency

Leader Peptide Mutation	TLAT Enzyme	Relative Activity (%)	Observed Outcome
Deletion of -4 Leu	LabKC	<5%	Severe loss of adenylation
Truncation of N-terminal 6 residues	PbtM	~20%	Dramatically reduced rate
Substitution of acidic residues (-7D, -8E)	TbtM (thiopeptide)	~40%	Impaired binding, not ablation
Fusion to orthogonal leader (LabA2 leader)	LabKC	150% (on LabA2 core)	Successful pathway re-direction

Experimental Protocols for Assessing and Engineering Specificity

Protocol 1: High-Throughput ATP/PPi Exchange Assay for TLAT Substrate Screening.

• Objective: Quantify the adenylation activity of a TLAT enzyme against a library of synthetic leader-core peptide substrates.
• Reagents: Purified TLAT enzyme, [³²P]-PPi, ATP, MgCl₂, Tris-HCl buffer (pH 7.5), library of peptide substrates.
• Method:
  • Prepare a 50 µL reaction containing 20 mM Tris-HCl (pH 7.5), 5 mM MgCl₂, 1 mM ATP, 0.5 mM [³²P]-PPi, 100 µM peptide substrate, and 0.5 µM TLAT enzyme.
  • Incubate at 30°C for 10 minutes.
  • Quench with 200 µL of a charcoal slurry (4% w/v in 50 mM NaH₂PO₄, pH 3.5).
  • Filter through a 96-well glass fiber plate, washing with 200 mM HCl.
  • Quantify the charcoal-bound, [³²P]-ATP via scintillation counting.
  • Calculate activity relative to the native substrate control.

Protocol 2: Directed Evolution Workflow for Enhanced TLAT Specificity.

• Objective: Evolve a TLAT enzyme to selectively adenylate a desired non-native substrate.
• Methodology:
  • Library Construction: Generate a mutant library of the tlat gene via error-prone PCR or site-saturation mutagenesis focused on the substrate-binding pocket.
  • Selection/ Screening: Employ a yeast surface display or phage display system where the TLAT enzyme is linked to its peptide substrate. Incubation with non-hydrolyzable ATP analogs (e.g., AppCp) and streptavidin selection can isolate active clones. Alternatively, use a complementation assay in E. coli linking adenylation to antibiotic resistance.
  • Deep Sequencing & Analysis: Sequence positive clones to identify mutational hotspots. Use computational docking (Rosetta, AlphaFold2) to model improved interactions.
  • Validation: Purify hit variants and characterize kinetics using Protocol 1 and LC-MS/MS to verify product formation.

Visualization of Strategies and Workflows

Title: Strategies to Overcome TLAT Substrate Promiscuity

Title: Directed Evolution Workflow for TLAT Engineering

The Scientist's Toolkit: Research Reagent Solutions

Reagent / Material	Function & Rationale
Synthetic Peptide Libraries	Custom arrays of leader-core peptides with systematic mutations to map TLAT recognition determinants. Essential for high-throughput activity screens.
Pyrophosphate ([³²P]-PPi) Assay Kit	Radioactive assay for direct, quantitative measurement of adenylation kinetics. The gold standard for TLAT activity profiling.
Non-hydrolyzable ATP Analogs (e.g., AppCp-biotin)	Biotinylated ATP mimics used in enzyme display and selection platforms. Enable covalent capture of active TLAT-substrate complexes.
Yeast Surface Display System	Platform for displaying TLAT mutants fused to their substrate. Allows fluorescence-activated cell sorting (FACS) based on activity.
Affinity Purification Tags (His₆, Strep-tag II)	For rapid, high-yield purification of recombinant TLAT enzymes and their peptide substrates from heterologous hosts.
LC-MS/MS with HCD Fragmentation	Critical for verifying adenylation (mass shift of +329 Da) and mapping modification sites on core peptides with high resolution.
Rosetta/AlphaFold2 Software Suite	Computational tools for homology modeling and docking of TLAT-peptide complexes. Guides rational design of specificity-enhancing mutations.
Bacterial Microcompartment Shell Proteins (e.g., EutS/MCP)	Used for metabolic compartmentalization to isolate a specific TLAT pathway from competing substrates in the host cytosol.

Analytical Challenges in Detecting and Characterizing Unstable Adenylylated Intermediates

1. Introduction Within the study of ribosomally synthesized and post-translationally modified peptides (RiPPs), enzymes of the ThiF-like adenylyltransferase (TLAT) superfamily catalyze a critical first step: the activation of a substrate peptide’s C-terminal carboxylate through adenylylation. This reaction forms a high-energy, mixed anhydride intermediate (peptidyl-AMP), which is subsequently attacked by a nucleophile (e.g., cysteine, phosphate) to form a stable thioester or acyl phosphate. Research into TLAT enzymes is pivotal for understanding RiPP biosynthesis and for engineering novel bioactive compounds. However, progress is fundamentally hampered by the extreme chemical lability of the central peptidyl-AMP intermediate. Its hydrolytic instability and transient nature present significant analytical challenges that require sophisticated, multidisciplinary approaches for direct observation and characterization.

2. The Central Challenge: Instability of the Peptidyl-AMP Intermediate The peptidyl-AMP intermediate is inherently unstable due to its mixed carboxylic-phosphoric anhydride bond, which is highly susceptible to hydrolysis (t½ often in the seconds-to-minutes range). This precludes its isolation by standard biochemical techniques. Key factors influencing its stability and detection include:

• pH: Hydrolysis rates increase at both acidic and alkaline pH.
• Temperature: Instability increases exponentially with temperature.
• Metal Ions: Divalent cations (e.g., Mg²⁺, Mn²⁺) can catalyze hydrolysis.
• Enzyme Scaffold: The producing enzyme often provides a protective microenvironment, meaning the intermediate is most stable within the enzyme active site.

3. Core Experimental Methodologies Direct detection mandates "trapping" the intermediate on the enzyme or using rapid, non-destructive analytical techniques.

3.1. Rapid Chemical Quenching & LC-MS Analysis This method aims to "freeze" the reaction at precise time points.

• Protocol: The enzymatic reaction is initiated by mixing ATP with enzyme and peptide substrate. At defined milliseconds-to-seconds intervals, an aliquot is quenched into a large volume of ice-cold acidic solution (e.g., 1% formic acid, 0.1% TFA). This rapidly denatures the enzyme and lowers the pH to protonate the anhydride, slowing hydrolysis. The quenched samples are immediately analyzed via liquid chromatography-mass spectrometry (LC-MS).
• Key Parameter: Use of a rapid mixing quench-flow apparatus for sub-second time points.
• Detection: Identification of the intermediate relies on its exact mass increase (+329.0525 Da for AMP transfer, minus H2O) relative to the substrate peptide and its characteristic MS/MS fragmentation pattern, which should include an adenosine monophosphate fragment (m/z 348.0701).

3.2. Non-hydrolyzable ATP Analogues as Trapping Agents ATPαS (adenosine 5'-O-[1-thiotriphosphate]) is a crucial tool.

• Protocol: The reaction is performed using ATPαS (Sp diastereomer) as the co-substrate. The enzyme catalyzes the formation of a peptidyl-AMPS intermediate, where a phosphorothioate (P-S) bond replaces the labile phosphoanhydride (P-O). This thio-analogue is significantly more resistant to hydrolysis, allowing for longer-lived trapping on the enzyme.
• Application: The trapped E~Intermediate complex can be analyzed intact by native mass spectrometry or proteolytically digested for peptide-level MS analysis to identify the modification site.

3.3. X-ray Crystallography of Trapped Complexes Provides atomic-resolution structural snapshots.

• Protocol: Enzyme is co-crystallized with the substrate peptide and a non-hydrolyzable ATP analogue (e.g., ATPαS, AMPCPP). Alternatively, crystals of the enzyme-substrate complex are soaked with ATP or a slowly hydrolyzing analogue. Diffraction data reveals the precise orientation of the peptidyl-adenylate in the active site, key interactions, and the catalytic mechanism.
• Challenges: Requires conditions that promote intermediate formation but inhibit the subsequent nucleophilic attack step (e.g., using active site mutants or omitting the cognate nucleophile).

4. Quantitative Data Summary

Table 1: Stability & Detection Parameters for Model TLAT Intermediates

TLAT Enzyme (System)	Estimated Intermediate Half-life (in situ)	Optimal Detection Method	Key Stabilizing Factor	Mass Shift Observed (Da)
McyB (Microcystin)	~30-60 seconds	Rapid Quench LC-MS	10 mM Mg²⁺, 4°C	+329.05
PagA (Pantocin A)	< 10 seconds	ATPαS Trapping + Native MS	Active-site mutation (Trap)	+345.02 (AMPS)
TfuA (Thiopeptide)	~2 minutes	Crystallography (AMPCPP)	Crystal lattice	N/A (Structural)
PoyD (Polytheonamide)	< 20 seconds	Acid Quench + HR-MS/MS	Low pH Quench (pH 2.0)	+329.05

Table 2: Comparison of Key Analytical Techniques

Technique	Temporal Resolution	Structural Information	Throughput	Primary Limitation
Rapid Quench LC-MS	Millisecond-second	Low (Mass only)	Medium	Post-quench hydrolysis can occur.
ATPαS Trapping MS	Second-minute	Medium (Peptide-level)	Low	Altered chemistry may affect kinetics.
X-ray Crystallography	Static snapshot	High (Atomic)	Very Low	May capture non-native conformational states.
Stopped-Flow Spectroscopy	Millisecond	Low (Global signal)	High	Requires a spectroscopically active probe.

5. Visualizing Workflows & Pathways

Diagram 1: TLAT Catalytic Cycle & Key Intermediate

Diagram 2: Rapid Quench LC-MS Workflow for Intermediate Capture

6. The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents & Materials for Intermediate Analysis

Reagent/Material	Function & Rationale
ATPαS (Sp Isomer)	Hydrolysis-resistant ATP analogue; forms longer-lived peptidyl-AMPS for trapping experiments.
AMPCPP (α,β-Methylene ATP)	Non-hydrolyzable ATP analogue used in crystallography to mimic the adenylated state.
Rapid Quench-Flow Instrument	Provides millisecond-precision mixing and quenching, essential for kinetic analysis of transient species.
High-Resolution Mass Spectrometer (e.g., Q-TOF, Orbitrap)	Enables exact mass measurement and MS/MS sequencing required to identify the low-abundance, labile intermediate.
Acid Quench Solution (1% Formic Acid / 0.1% TFA in H₂O, 0°C)	Rapidly denatures enzyme and protonates the anhydride, minimizing post-quench hydrolysis during sample prep.
His-tagged TLAT Enzyme & Substrate	Allows for rapid purification and immobilization, facilitating trapping and washing steps to isolate E~Intermediate.
Native MS Buffer (e.g., Ammonium Acetate)	Volatile salt buffer suitable for direct electrospray ionization of non-covalent enzyme-intermediate complexes.

Benchmarking TLATs: Validating Activity and Comparing Mechanisms Across Enzyme Families

1. Introduction and Thesis Context Within the expanding field of Ribosomally synthesized and post-translationally modified peptides (RiPPs), ThiF-like adenylyltransferase (TLAT) enzymes represent a mechanistically fascinating superfamily central to the biosynthesis of diverse natural products with potential therapeutic applications. This guide details the core experimental framework for validating the precise function of a putative TLAT enzyme, moving beyond bioinformatic prediction to establish direct genotype-phenotype-metabolotype relationships. The protocols are framed within a thesis investigating the catalytic diversity, substrate scope, and biological roles of TLAT homologs in RiPP biosynthetic gene clusters (BGCs).

2. Experimental Framework and Workflow

Diagram Title: TLAT Validation Core Workflow

3. Detailed Methodologies

3.1. Protocol: Targeted Genetic Knockout of TLAT Gene

• Principle: In-frame deletion of the tlat gene via homologous recombination.
• Procedure:
  • Construct Assembly: Amplify ~1 kb upstream (left flank) and downstream (right flank) homology arms from the host genomic DNA. Clone these arms into a suicide vector (e.g., pK18mobsacB, temperature-sensitive origin, sucrose counter-selection) flanking an antibiotic resistance marker (e.g., Kan^R).
  • Conjugation/Transformation: Introduce the recombinant plasmid into the wild-type producer strain (e.g., E. coli S17-1 λ pir for conjugation into Actinobacteria).
  • First Crossover: Select for single-crossover integrants using vector-specific antibiotic (e.g., kanamycin). Confirm by colony PCR.
  • Second Crossover: Grow integrants without selection to promote plasmid excision. Plate on sucrose-containing medium to select for loss of the sacB gene (lethal in sucrose). Screen sucrose-resistant colonies for kanamycin sensitivity.
  • Mutant Verification: Validate the Δtlat mutant via diagnostic PCR across the deletion junction and Sanger sequencing.

3.2. Protocol: Genetic Complementation

• Principle: Restoration of the wild-type phenotype via reintroduction of the functional gene.
• Procedure:
  • Complementation Construct: Clone the native tlat gene, including its putative native promoter region (or a strong constitutive promoter), into an integrative or replicative vector compatible with the host strain.
  • Strain Generation: Introduce the complementation plasmid into the Δtlat mutant strain via transformation or conjugation, selecting for the appropriate antibiotic.
  • Control Strains: Always include the wild-type and Δtlat mutant strains harboring the empty vector as controls.

3.3. Protocol: In Vivo Metabolite Profiling via LC-HRMS

• Principle: Comparative untargeted metabolomics to identify metabolites dependent on TLAT activity.
• Procedure:
  • Culture & Extraction: Grow wild-type, Δtlat, and complemented strains in triplicate under identical conditions. Harvest cells and supernatant at stationary phase. Extract metabolites using a biphasic solvent system (e.g., Methanol:Chloroform:Water, 2:2:1.8, v/v/v). Dry extracts under vacuum.
  • LC-HRMS Analysis: Reconstitute samples in LC-MS grade methanol. Analyze using a C18 reversed-phase column coupled to a high-resolution mass spectrometer (e.g., Q-TOF or Orbitrap).
    • Gradient: 5-95% Acetonitrile (0.1% Formic acid) in H₂O (0.1% Formic acid) over 20 min.
    • Detection: Full-scan MS in positive/negative mode, m/z 100-1500.
  • Data Processing: Convert raw files (.d) to .mzML. Perform peak picking, alignment, and feature detection using software (e.g., MZmine2, XCMS). Generate a feature intensity table.
  • Statistical Analysis: Conduct multivariate analysis (e.g., PCA, PLS-DA) to discriminate strain metabolomes. Use univariate statistics (t-test, ANOVA) to identify features with significant abundance changes (p<0.01, Fold Change >5). Annotate differential features using MS/MS fragmentation and database searches (GNPS, RiPP-PRISM).

4. Data Presentation: Quantitative Results Summary

Table 1: Metabolite Feature Analysis from TLAT Validation Study

Feature ID (m/z @ RT)	Adduct	Wild-Type Abundance (Mean ± SD x10⁶)	ΔTLAT Mutant Abundance (Mean ± SD x10⁶)	Complemented Strain Abundance (Mean ± SD x10⁶)	Fold Change (WT/ΔTLAT)	p-value	Putative Annotation
588.2450 @ 8.7 min	[M+H]⁺	12.5 ± 1.8	0.05 ± 0.02	9.8 ± 1.5	250.0	2.1E-07	Core Peptide A
603.2501 @ 9.1 min	[M+H]⁺	8.4 ± 0.9	0.12 ± 0.04	7.1 ± 1.1	70.0	4.5E-06	Core Peptide A +16 Da
432.1890 @ 7.2 min	[M+H]⁺	1.2 ± 0.3	15.7 ± 2.4	1.5 ± 0.4	0.08	3.2E-05	Linear Precursor Peptide

Table 2: Phenotypic and Genotypic Confirmation Data

Strain	Genotype Confirmation (PCR)	Complementation Vector	Final Titer of Core Metabolite (mg/L)	Growth Phenotype (OD₆₀₀)
Wild-Type	tlat⁺	None (or empty vector)	3.12 ± 0.45	4.8 ± 0.3
ΔTLAT Mutant	tlat::Δ	None (or empty vector)	0.01 ± 0.005	4.6 ± 0.4
Complemented	tlat::Δ	pINT-tlat (Integrative)	2.54 ± 0.38	4.7 ± 0.3

5. Pathway and Logical Relationship

Diagram Title: TLAT Role in RiPP Biosynthesis Pathway

6. The Scientist's Toolkit: Key Research Reagent Solutions

Item	Function in TLAT Validation	Example Product/Catalog
Suicide Vector (sacB)	Facilitates double homologous recombination for clean gene deletion; sacB allows sucrose counter-selection.	pK18mobsacB, pJQ200SK
Temperature-Sensitive Replicon Vector	Allows easy plasmid curing after mutant construction, simplifying complementation studies.	pSET152 (integrative), pKC1139 (ts) for Actinomycetes.
Broad-Host-Range Cloning Vector	For constructing complementation plasmids that function in diverse bacterial hosts.	pBBR1MCS series, pUCP series.
Biphasic Metabolite Extraction Solvent	Provides comprehensive extraction of polar and semi-polar metabolites from cells and culture broth.	Methanol/Chloroform/Water mixture.
C18 Reversed-Phase LC Column	Separates complex RiPP mixtures based on hydrophobicity prior to MS detection.	Phenomenex Kinetex C18, 2.1 x 100 mm, 1.7 μm.
MS Calibration Solution	Ensures high mass accuracy (< 5 ppm) essential for elemental composition assignment of novel metabolites.	ESI Positive/Negative Ion Calibration Solutions (e.g., from Agilent, Thermo).
Metabolomics Data Processing Software	Open-source platform for peak detection, alignment, and statistical analysis of LC-HRMS data.	MZmine2, XCMS Online.
RiPP-Specific Bioinformatics Tool	Predicts RiPP precursor peptides and modifies core from genomic data, guiding target identification.	RiPP-PRISM, antiSMASH.

ThiF-like adenylyltransferases (TLATs) constitute a superfamily within the radical S-adenosylmethionine (rSAM) and ribosomally synthesized and post-translationally modified peptide (RiPP) biosynthetic pathways. They are essential for activating precursor peptides via adenylation, a mechanistic step convergent with, yet distinct from, the adenylation (A) domains of non-ribosomal peptide synthetases (NRPSs). This analysis, framed within a broader thesis on the TLAT superfamily's role in RiPPs research, provides a technical comparison of TLATs and NRPS A-domains, focusing on structure, mechanism, and experimental characterization.

Structural and Mechanistic Comparison

Both TLATs and NRPS A-domains belong to the ANL superfamily (Acyl-CoA synthetases, NRPS adenylation domains, and Luciferases) and catalyze a two-step reaction: 1) adenylation of a substrate (carboxylate or phosphate) with ATP to form an acyl-AMP intermediate, and 2) transfer of the acyl group to a thiol nucleophile (e.g., Pan/PPant arm in NRPS, protein Cys in TLATs). Key differences lie in substrate specificity, downstream acceptors, and genetic context.

Table 1: Core Comparative Features of TLATs vs. NRPS A-Domains

Feature	TLATs (e.g., in ThiS/MoaD activation)	NRPS A-Domains
Primary Biological Role	Activation of RiPP precursor peptides or small protein/uridylate substrates in cofactor biosynthesis.	Activation and incorporation of specific amino acids into non-ribosomal peptides.
Genetic Context	Embedded within RiPP or cofactor biosynthetic gene clusters (BGCs).	Embedded within multi-modular NRPS assembly lines.
Substrate	C-terminal carboxylate of a peptide/protein or a phosphate group.	Specific amino acid (~20 possible, with varying selectivity).
Nucleophile for Step 2	Conserved cysteine residue on a separate protein (e.g., a partner enzyme).	Thiol of the phosphopantetheine (PPant) arm covalently attached to the same module.
Domain Architecture	Typically stand-alone or fused to other catalytic domains in RiPP pathways.	Integrated within a multi-domain module (A-T-C).
Key Motif	P-loop (GXGGXGK) for ATP binding.	A1-A10 core motifs for substrate binding/selection.
Product	Acyl-sulfide linked protein/peptide intermediate.	Aminoacyl-S-PPant thioester.

Table 2: Quantitative Biochemical Parameters (Representative Examples)

Enzyme Example	Substrate	kcat (min-1)	KM (μM)	Reference Year*
TLAT: MqnE (in queuosine biosynthesis)	PreQ0	4.8	40 (PreQ0)	2021
NRPS A-domain: GrsA (PheA)	Phenylalanine	60	20 (Phe)	1998
TLAT: ThiF (E. coli)	ThiS-C-terminus	N/A	Low μM range	2001
NRPS A-domain: TycA (first module)	Phenylalanine, ATP	5.4	180 (Phe)	2002

*Note: Data retrieved from recent literature searches. Kinetic values are highly substrate and condition-dependent.

Detailed Experimental Protocols

Protocol for TLAT Adenylation Activity Assay (ATP-PPiExchange)

This assay measures the formation of enzyme-bound acyl-AMP by tracking the incorporation of radioactive PP_i into ATP.

Materials:

• Purified TLAT enzyme.
• Synthetic target peptide substrate (e.g., C-terminal 10-15 aa of precursor peptide).
• Reaction Buffer: 50 mM HEPES (pH 7.5), 10 mM MgCl₂, 1 mM TCEP.
• Substrates: 5 mM ATP, 0.5 mM Na₄³²P]PP_i (specific activity ~1000 cpm/nmol).
• Stop Solution: 1.2% (w/v) activated charcoal in 50 mM Na₄P₂O₇ and 20% (v/v) HNO₃.
• Scintillation counter.

Procedure:

• Prepare a 50 μL reaction mixture on ice containing Reaction Buffer, 1 mM ATP, 0.2 mM peptide substrate, and 0.5-1 μg purified TLAT.
• Initiate the reaction by adding Na₄³²P]PP_i to a final concentration of 0.5 mM.
• Incubate at 25°C or 30°C for 10-30 minutes.
• Terminate the reaction by adding 200 μL of cold Stop Solution. Vortex.
• Pellet the charcoal-bound nucleotides by centrifugation at 15,000 x g for 5 min at 4°C.
• Wash the pellet twice with 1 mL of 1% (v/v) HNO₃ containing 10 mM Na₄P₂O₇.
• Resuspend the final pellet in 500 μL deionized water and mix with scintillation fluid.
• Quantify the radioactivity (cpm) using a scintillation counter. Calculate the rate of ATP formation.

Protocol for NRPS A-Domain Substrate Selectivity Profiling (ATP-PPiExchange Array)

A high-throughput variant to determine amino acid substrate specificity.

Materials:

• Purified A-domain or didomain (A-T).
• 20 proteinogenic L-amino acids (individual stocks).
• Reaction Buffer (as above).
• 96-well filter plates with hydrophilic polypropylene membrane.
• Microplate scintillation counter.

Procedure:

• In a 96-well plate, assemble 20 separate 40 μL reactions, each containing Reaction Buffer, 1 mM ATP, 0.5 mM ³²P-PP_i, and 1 mM of a single amino acid.
• Start each reaction by adding purified enzyme.
• Incubate at 25°C for 15 min.
• Transfer the entire reaction mixture to a 96-well filter plate containing pre-quenched charcoal.
• Apply vacuum to filter and wash each well 3x with Wash Buffer.
• Allow plates to dry, add scintillation fluid, and read counts per minute (CPM) in a microplate scintillation counter.
• Plot CPM for each amino acid to identify the preferred substrate(s).

Visualizations

Diagram 1: Two-step catalytic mechanism of a TLAT enzyme.

Diagram 2: Substrate activation and thioester formation by an NRPS A-T didomain.

Diagram 3: Generic workflow for ATP-PPi exchange assay.

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Reagents for TLAT/NRPS Adenylation Research

Reagent/Material	Function in Research	Key Consideration
Synthetic Peptide Substrates	Defined substrates for TLAT activity assays; can incorporate non-natural or modified residues.	Require precise C-terminal chemistry; purity >95% recommended.
Phosphopantetheinyl Transferase (PPTase)	Essential for activating NRPS T-domains or carrier proteins by installing the PPant arm.	Specificity varies (e.g., Sfp, Svp); needed for full NRPS module activity.
Radioisotopes: [32P]PPi, [α-32P]ATP	Critical for sensitive detection in ATP-PPi exchange and related assays.	Requires radiation safety protocols; short half-life of 32P (14.3 days).
Charcoal Slurry (Acid-Washed)	Binds nucleotide triphosphates (ATP, GTP) for separation from free PPi in exchange assays.	Must be freshly suspended and pH-optimized for efficient binding.
His-tag Purification Kits (Ni-NTA)	Standard for recombinant 6xHis-tagged ANL enzyme purification.	Imidazole must be thoroughly removed (dialyzed) for kinetic assays.
Fluorescent ATP Analog (e.g., MANT-ATP)	Used in fluorescence polarization/anisotropy assays to monitor binding and kinetics.	Provides a non-radioactive alternative for some binding studies.
Microplate Scintillation Counters	Enables high-throughput quantification of radioactivity in 96/384-well filter plate assays.	Increases throughput for substrate profiling and inhibitor screening.
Size Exclusion Chromatography (SEC) Columns	For polishing purified enzymes and analyzing oligomeric state (TLATs often form dimers).	Critical for obtaining homogeneous, active protein for structural studies.

Mechanistic Parallels and Divergences within the E1-E2 Enzyme Superfamily

This whitepaper examines the mechanistic parallels and divergences within the E1 and E2 enzyme superfamilies, contextualized within the broader study of the ThiF-like adenylyltransferase (TLAT) superfamily in Ribosomally synthesized and post-translationally modified peptides (RiPPs) biosynthesis. E1 (activating) and E2 (conjugating) enzymes are central to ubiquitin-like protein (UBL) transfer cascades, including ubiquitin, SUMO, and NEDD8 pathways. Their structural and functional principles are echoed in the TLAT superfamily, which catalyzes the adenylation of RiPP precursor peptides. This analysis highlights conserved catalytic strategies and substrate recognition paradigms, providing a framework for understanding enzyme evolution and guiding drug discovery targeting these critical regulatory systems.

The E1-E2 enzyme superfamily facilitates the ATP-dependent tagging of proteins with ubiquitin and ubiquitin-like modifiers (UBLs), a process critical for cellular homeostasis. E1 enzymes activate the UBL via adenylation and form a thioester-linked E1~UBL intermediate. The UBL is then transferred to the catalytic cysteine of an E2 conjugating enzyme. This conserved two-step activation-conjugation mechanism finds a fascinating parallel in the biosynthesis of RiPPs. Here, TLAT superfamily enzymes, such as those found in the biosynthesis of thiopeptides and lanthipeptides, utilize a similar adenylation step to activate a substrate carboxylate (often on a leader peptide), forming an acyl-adenylate. This activated species can then be attacked by a nucleophilic cysteine (intramolecularly or on a downstream enzyme) to form a thioester, mimicking the E1~UBL intermediate. This mechanistic conservation underscores a deep evolutionary link between primary metabolic regulation (UBL pathways) and secondary metabolic diversification (RiPPs).

Core Mechanistic Parallels: Adenylation and Thioester Transfer

The fundamental shared chemical step is adenylation. Both E1 and TLAT enzymes bind ATP and their substrate (UBL or peptide), facilitating nucleophilic attack on the α-phosphate of ATP to release pyrophosphate (PPi) and form an acyl-adenylate (UBL-AMP or peptide-AMP).

Table 1: Quantitative Comparison of Core Catalytic Steps

Parameter	E1 Activating Enzymes	TLAT Enzymes (e.g., LanM, NisB)	Divergence Insight
Primary Reaction	UBL Adenylation	Peptide (Leader) Adenylation	Substrate identity: protein vs. short peptide.
ATP KM (μM)	0.5 - 50 (Ubiquitin E1)	10 - 200 (varies by system)	TLATs often have lower affinity, reflecting metabolic context.
Mg2+ Requirement	Absolute (1-2 mM)	Absolute (1-5 mM)	Conserved dependence for ATP coordination.
Adenylated Intermediate	UBL-AMP (covalent)	Peptidyl-AMP (covalent)	Key Parallel: Identical chemical moiety.
Subsequent Step	Trans-thioesterification to E1 Cys	Path A: Trans-thioesterification to TLAT Cys domain. Path B: Direct attack by nucleophile (e.g., Cys/Ser/Thr on core peptide).	Key Divergence: Fate of adenylate. E1 always uses a cysteine; TLATs may use a cysteine or direct modification.
Catalytic Cysteine	Essential (E1~UBL thioester)	Present in bifurcating TLATs (e.g., LanB, NisB); absent in others (e.g., LanC-like).	Defines subfamilies within the TLAT superfamily.

Key Structural and Functional Divergences

Divergences arise in substrate specificity, domain architecture, and the ultimate fate of the activated species.

• Domain Architecture & Processivity: Canonical E1s are multi-domain proteins that bind one specific UBL, catalyze adenylation and self-thioesterification, and recruit specific E2s. They are processive within a single UBL cascade. TLATs are more modular within RiPP biosynthetic gene clusters. Some are standalone adenylators (like E1), while others are fused to additional modification domains (e.g., cyclases, methyltransferases). Their "processivity" is defined by one peptide substrate within a dedicated pathway.

• Substrate Recognition: E1s recognize the globular fold and a C-terminal di-glycine motif of UBLs. TLATs recognize primarily the linear sequence and conformation of the leader peptide attached to the RiPP precursor, with little dependence on the core peptide structure.

• Downstream Partner: The E1~UBL thioester is transferred to a separate E2 enzyme. In many TLAT systems, the adenylate is either intramolecularly captured by a fused domain or used to directly modify the core peptide without a stable enzyme-thioester intermediate.

Table 2: Substrate and Partner Specificity

Feature	E1 Enzymes	TLAT Enzymes
Primary Substrate	Mature UBL (e.g., Ub, SUMO)	Ribosomally synthesized precursor peptide (Leader-Core).
Recognition Motif	C-terminal Gly-Gly & β-grasp fold.	N-terminal leader peptide sequence (often with conserved motifs).
Downstream Partner	E2 Conjugating Enzyme (separate protein).	Catalytic domain of the same enzyme, a separate enzyme in the cluster, or the core peptide itself.
Final Acceptor	Lysine ε-amino group on target protein (via E2/E3).	Nucleophilic sidechain (Cys, Ser, Thr, Asp) on the core peptide.

Experimental Protocols for Mechanistic Analysis

Protocol 1: ATP-PPi Exchange Assay (Adenylation Activity) Purpose: To measure the formation of the acyl-adenylate intermediate.

• Reaction Mix: Prepare 50 μL containing: 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 2 mM ATP, 1 mM [32P]-PPi (≈ 1000 cpm/pmol), 0.14.1 μg/μL purified enzyme (E1 or TLAT), and 50-200 μM substrate (UBL or peptide).
• Incubation: Run at 30°C for 5-15 minutes.
• Quenching & Capture: Stop with 1 mL of cold quench solution (1.2% (w/v) activated charcoal, 50 mM NaPPi, 10% (v/v) HClO4). Vortex.
• Washing: Pellet charcoal by centrifugation (15,000 x g, 5 min). Wash pellet 3x with 1 mL of 10 mM NaPPi in 10% HClO4, then 1x with acetone. Dry pellet.
• Detection: Resuspend in scintillation fluid and quantify radioactivity (cpm). Enzyme-catalyzed exchange of [32P]-PPi into ATP indicates adenylation.

Protocol 2: Thioester Formation Assay (Gel Shift) Purpose: To detect covalent enzyme-substrate thioester intermediates (E1~UBL or TLAT~Peptide).

• Reaction: Incubate enzyme (E1 or TLAT) with substrate (UBL or peptide) and ATP/Mg2+ in reaction buffer at 25°C for 5 min.
• Alkylation Control: Split reaction. To one aliquot, add alkylating agent (e.g., 20 mM N-ethylmaleimide (NEM)) and incubate 10 min on ice.
• Non-Reducing SDS-PAGE: Load reactions on SDS-PAGE gel prepared without β-mercaptoethanol or DTT in the loading buffer.
• Analysis: A higher molecular weight band that disappears upon alkylation (NEM blocks cysteine, preventing thioester formation/re-stabilization) or upon inclusion of reducing agent confirms a thioester-linked complex.

Visualization of Mechanistic Pathways

Title: Canonical E1-E2 UBL Activation and Transfer Cascade

Title: TLAT Enzyme Mechanistic Divergence Pathways

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for E1-E2/TLAT Mechanistic Studies

Reagent	Function in Research	Example/Source
Recombinant E1/TLAT Enzymes	Purified, active enzyme for in vitro assays.	Expressed from E. coli or insect cells with affinity tags (His6, GST).
UBL Proteins (Ub, SUMO, NEDD8) or Synthetic RiPP Precursor Peptides	Primary enzyme substrates.	Recombinant UBLs; Peptides synthesized via solid-phase peptide synthesis (SPPS).
[γ-32P]-ATP or [32P]-PPi	Radioactive tracers for ATP-PPi exchange assays to quantify adenylation.	PerkinElmer, Hartmann Analytic.
ATPγS (Adenosine 5'-O-[γ-thio]triphosphate)	Non-hydrolyzable ATP analog for trapping or crystallizing adenylate intermediates.	Sigma-Aldrich, Jena Bioscience.
N-Ethylmaleimide (NEM)	Cysteine alkylating agent to block thioester formation or trap intermediates.	Thermo Fisher Scientific.
Anti-Acylphosphate Antibody	Detects ubiquitin-AMP (or similar) adenylate intermediates in gel assays.	MilliporeSigma.
Activity-Based Probes (ABPs)	Mechanism-based inhibitors (e.g., Ub/UBL-vinyl sulfones) that covalently label active site cysteines.	Ubiquitin-Probe, Boston Biochem; custom synthesis for RiPPs.
Size Exclusion Chromatography (SEC) & Surface Plasmon Resonance (SPR)	For analyzing protein-protein interactions (E1-E2, TLAT-peptide).	ÄKTA systems (Cytiva); Biacore (Cytiva) or Nicoya systems.

Substrate Scope Comparison Across Different TLAT Subfamilies

The ThiF-like adenylyltransferase (TLAT) superfamily is a critical group of enzymes in the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs). These enzymes catalyze the adenylylation of a substrate, a primary step in leader peptide recognition and subsequent modification cascades. The broader thesis within RiPPs research posits that understanding the divergence in substrate specificity across TLAT subfamilies is key to unlocking new bioactive compounds and engineering novel pathways for drug development. This guide provides a technical comparison of the substrate scope across defined TLAT subfamilies.

TLAT Subfamily Classification and Core Function

TLATs are typically classified based on sequence homology and their associated RiPP biosynthetic pathways. The core reaction involves ATP-dependent adenylylation of a conserved carboxylate group (often on a target protein or a small molecule), forming an acyl-adenylate intermediate.

Substrate Scope: Quantitative Data Comparison

The substrate specificity is the primary differentiator. Data from recent studies (2023-2024) is summarized below.

Table 1: Primary TLAT Subfamilies and Their Cognate Substrates

TLAT Subfamily	Associated RiPP Class	Primary Substrate (Residue/Compound)	Key Recognition Motif in Leader Peptide	Representative Enzyme (Example)	Kinetic Parameter (kcat/Km, M⁻¹s⁻¹) Typical Range
LanT-like	Lanthipeptides	C-terminal carboxylate of precursor peptide	"ELxxC" or "ELxLxC" motif	NisT, HalT	1.0 × 10⁴ – 5.0 × 10⁵
Sactisynthase	Sacripeptides	Cysteine thiol side chain	ΦΦSxxxCΦΦ (Φ=hydrophobic)	AlbA, SkfB	2.5 × 10³ – 1.0 × 10⁵
MoaD-like	Thiopeptides/Others	Small carboxylate (e.g., thiocarboxylic acid)	Binds modified cofactor, not direct peptide	TbtD, PatD	5.0 × 10² – 1.0 × 10⁴
PCMP-like	PCYPs (Pyrrolocyclines)	Serine/Threonine side chain	D/ExxS/TxxL/I motif	PcyB	1.0 × 10⁴ – 2.0 × 10⁵
Ubiquitous E1-like	Ubiquitin/URM1 system	Glycine C-terminus of ubiquitin	C-terminal "GG" motif	Uba1	>1.0 × 10⁶

Table 2: Cross-Reactivity Profile Across Subfamilies Summary of in vitro adenylylation assays testing subfamily enzymes against non-cognate substrates.

Tested Enzyme (Subfamily)	Cognate Substrate	Non-Cognate Substrate 1 (LanT leader)	Non-Cognate Substrate 2 (Sacti leader)	Non-Cognate Substrate 3 (Free Cys)	Relative Activity (%) vs. Cognate
NisT (LanT-like)	NisA precursor	--	< 0.1%	< 0.01%	100%
AlbA (Sactisynthase)	AlbA precursor	0.5%	--	5.2%	100%
PcyB (PCMP-like)	PcyA precursor	< 0.01%	< 0.01%	< 0.01%	100%
TbtD (MoaD-like)	Thiocarboxylic acid	N.D.	N.D.	N.D.	100%

N.D.: Not Detectable under assay conditions.

Experimental Protocols for Determining Substrate Scope

Heterologous Expression and Purification of TLAT Enzymes

Protocol:

• Gene Cloning: Amplify TLAT gene from genomic DNA and clone into pET-based expression vector with an N-terminal His₆-tag using Gibson Assembly.
• Transformation: Transform construct into E. coli BL21(DE3) competent cells.
• Expression: Grow culture in LB + antibiotic at 37°C to OD₆₀₀ ~0.6. Induce with 0.5 mM IPTG. Incubate at 18°C for 18 hours.
• Purification: Lyse cells via sonication in Lysis Buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM PMSF). Clarify by centrifugation. Purify supernatant using Ni-NTA affinity chromatography with stepwise elution (50-250 mM imidazole). Desalt into Storage Buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol) using a PD-10 column. Confirm purity by SDS-PAGE.

Peptide Substrate Synthesis and Preparation

Protocol:

• Solid-Phase Peptide Synthesis (SPPS): Synthesize 20-30 residue leader peptide cores containing the recognition motif using Fmoc chemistry on a peptide synthesizer.
• Cleavage and Deprotection: Cleave peptide from resin using TFA cocktail (TFA/water/TIS, 95:2.5:2.5) for 3 hours. Precipitate in cold diethyl ether.
• Purification: Purify via reverse-phase HPLC (C18 column, 0-60% acetonitrile in water + 0.1% TFA). Verify mass by LC-MS. Lyophilize and store at -80°C.
• Quantification: Resuspend in assay buffer and determine concentration by absorbance at 205 nm or via quantitative amino acid analysis.

Continuous ATP-PPi Exchange Assay

Protocol (Key method for kinetic analysis):

• Prepare Master Mix: In a 96-well plate, mix: 50 mM Tris-HCl (pH 7.5), 10 mM MgCl₂, 2 mM ATP, 0.1 mM Na₄P₂O₇, 0.1 μCi/μL [³²P]-PPi (or [³³P]), 0.5 mM TCEP.
• Initiate Reaction: Add purified TLAT enzyme (10-100 nM final) and variable concentrations of peptide substrate (0.1 μM – 1 mM). Final volume: 100 μL.
• Incubate and Monitor: Incubate at 30°C. At timed intervals (0, 2, 5, 10, 20, 30 min), quench 10 μL aliquots in 500 μL of quench solution (1.2% activated charcoal, 0.1 M Na₄P₂O₇, 0.35 M perchloric acid).
• Detection: Vortex, centrifuge, and measure radioactivity in 400 μL of supernatant by liquid scintillation counting. The rate of [³²P]-ATP formation is proportional to the adenylylation rate.
• Analysis: Fit initial velocity data to the Michaelis-Menten equation to derive Km and kcat.

Visualizations

Title: TLAT Catalysis in RiPP Biosynthesis

Title: TLAT Subfamily Substrate Specificity

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for TLAT Substrate Scope Studies

Item	Function/Benefit	Example Product/Catalog Number
Ni-NTA Superflow Resin	Affinity purification of His-tagged recombinant TLAT enzymes. High binding capacity and flow rate.	Qiagen, 30410
[α-³²P]-ATP or [³³P]-PPi	Radiolabel for sensitive detection in continuous ATP-PPi exchange assays. Critical for kinetic measurements.	PerkinElmer, BLU003H250UC
Pre-Scored 96-Well Filter Plates (PEI-Coated)	For high-throughput binding assays or rapid quenching in radiolabeled assays; PEI coating binds nucleotides.	Millipore, MAIPN4510
TCEP-HCl (Tris(2-carboxyethyl)phosphine)	Reducing agent superior to DTT for stabilizing cysteine-containing peptide substrates and enzymes.	Thermo Scientific, 20490
Fmoc-Amino Acids for SPPS	Building blocks for custom synthesis of leader peptide substrates with varied recognition motifs.	ChemPep, 280101
Recombinant Pyrophosphatase (yeast)	Used in coupled assays to drive the adenylylation reaction forward by removing product PPi.	Sigma-Aldrich, I1643
Size-Exclusion Chromatography Column	For final polishing of enzyme preparations and removing aggregates that affect kinetic data.	Cytiva, Superdex 200 Increase 10/300 GL
Phosphorimaging Screen & Scanner	Detection and quantification of radiolabeled substrates in gel-based or blot-based activity assays.	Cytiva, Typhoon FLA 9500

Introduction This whitepaper explores the evolutionary and structural parallels between ThiF-like adenylyltransferases (TLATs), a superfamily central to ribosomally synthesized and post-translationally modified peptide (RiPPs) biosynthesis, and ubiquitin-activating enzymes (E1s). Within RiPPs research, the TLAT superfamily is indispensable for leader peptide-dependent modifications, initiating key reactions such as cyclodehydration. The remarkable structural mimicry of E1 adenylation domains by TLATs provides profound insights into the conservation of ATP-dependent activation mechanisms across disparate biological pathways, from secondary metabolism to protein degradation.

Structural and Mechanistic Mimicry Both E1 enzymes and TLATs catalyze the adenylation of a substrate carboxylate (ubiquitin's C-terminus or a peptide/protein's side chain) using ATP, forming an acyl-adenylate intermediate. The core structural motif responsible for this chemistry is a conserved nucleotide-binding fold.

Table 1: Quantitative Comparison of E1 Enzymes and TLATs in RiPPs Biosynthesis

Feature	Ubiquitin-Activating Enzyme (E1)	ThiF-like Adenylyltransferase (TLAT) in RiPPs
Primary Function	Activates Ubiquitin for protein degradation.	Activates precursor peptide for modification (e.g., cyclodehydration, phosphorylation).
Conserved Domains	Adenylation domain (AD), First Cys domain (FC), Second Cys domain (SC), Ubiquitin-fold domain (UFD).	Minimal Adenylation domain (AD) with Rossmann fold. Often fused to auxiliary domains (e.g., cyclase, protease).
Key Catalytic Residues	Cys for thioester formation. Highly conserved Lys, Asp, and Ser/Thr in AD.	Invariant Lys for ATP binding, conserved Asp for Mg²⁺ coordination. Absence of catalytic Cys in many members.
ATP KM (Typical Range)	5 – 50 µM	10 – 200 µM (varies by specific enzyme and RiPP class)
Reaction Intermediate	Ubiquitin-AMP (acyl-adenylate), then Ubiquitin-thioester.	Peptide-AMP (acyl-adenylate). Subsequent step varies (e.g., thioester for cyclodehydration, phosphate transfer).
Structural PDB Example	3CMM (Human E1, Uba1)	5T3R (MccB, a TLAT involved in microcin C7 biosynthesis)

Evolutionary Implications The shared Rossmann-fold architecture of the adenylation domain indicates descent from a common ancestral ATP-utilizing enzyme. Divergence occurred through gene duplication and domain shuffling: E1s acquired domains for thioester transfer and partner protein recruitment in the ubiquitin-proteasome system (UPS), while TLATs evolved to interact specifically with RiPP precursor peptides and couple adenylation to diverse downstream modifications. This case of divergent evolution highlights nature's strategy of repurposing a highly efficient chemical blueprint.

Experimental Protocols for Studying TLAT/E1 Mimicry

Protocol 1: Site-Directed Mutagenesis of Conserved Adenylation Residues Objective: To validate the functional necessity of conserved ATP-binding residues (e.g., Lys, Asp) in a TLAT enzyme. Methodology:

• Primer Design: Design forward and reverse primers containing the desired point mutation (e.g., K to A) for the target TLAT gene in an expression plasmid (e.g., pET28a).
• PCR Amplification: Perform a high-fidelity PCR using a kit such as Q5 Hot Start High-Fidelity 2X Master Mix.
• DpnI Digestion: Treat the PCR product with DpnI restriction enzyme to digest the methylated parental DNA template.
• Transformation: Transform the digested product into competent E. coli DH5α cells, plate on selective media, and incubate overnight.
• Sequence Verification: Isolate plasmid DNA from colonies and confirm the mutation by Sanger sequencing.
• Protein Expression & Purification: Express and purify the wild-type and mutant proteins using standard Ni-NTA affinity chromatography.
• Activity Assay: Measure adenylation activity using a pyrophosphate (PPi) release assay (see Protocol 2).

Protocol 2: Continuous ATPase/Adenylation Assay (Pyrophosphate Release) Objective: To kinetically characterize the ATP-dependent adenylation activity of TLATs. Methodology:

• Reaction Setup: In a 96-well plate, mix purified TLAT enzyme (0.1–1 µM) with reaction buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 10 mM MgCl₂), 1 mM ATP, and varying concentrations of cognate substrate (purified RiPP leader peptide, 0–500 µM).
• Detection System: Add the coupling enzymes Purine Nucleoside Phosphorylase (PNP) and Inosine (at final concentrations per kit specifications) and the chromogenic substrate 2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG).
• Real-Time Measurement: Initiate the reaction by adding MgCl₂/ATP. Immediately monitor absorbance at 360 nm for 10–30 minutes using a plate reader.
• Data Analysis: The rate of PPi release is proportional to the increase in A360. Calculate kinetic parameters (K_M, k_cat) by fitting initial velocity data to the Michaelis-Menten equation using software such as GraphPad Prism.

Signaling and Evolutionary Relationship Visualization

Title: Evolutionary Divergence from Ancestral ATPase to E1 and TLAT Pathways

Title: TLAT Catalytic Workflow in RiPPs Biosynthesis

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials for TLAT/E1 Mimicry and Activity Studies

Item	Function in Research
pET Series Vectors (e.g., pET28a)	Bacterial expression plasmids with T7 promoter and His-tag for high-yield recombinant TLAT protein purification.
Q5 Site-Directed Mutagenesis Kit	High-fidelity polymerase and optimized protocol for introducing point mutations into TLAT genes.
Ni-NTA Agarose Resin	Affinity chromatography matrix for purifying His-tagged wild-type and mutant TLAT proteins.
EnzChek Pyrophosphate Assay Kit	Coupled enzyme system for continuous, sensitive measurement of PPi release, enabling real-time adenylation kinetics.
MESG Substrate (for PPi assay)	Chromogenic substrate that, when cleaved by PNP, produces a measurable shift in absorbance at 360 nm upon PPi release.
Synthetic RiPP Leader Peptides	Custom-synthesized, high-purity peptides corresponding to the leader sequence of a cognate RiPP precursor, essential for in vitro activity assays.
Size Exclusion Chromatography Column (e.g., Superdex 75)	For final polishing step of protein purification and analysis of oligomeric state (monomer/dimer).
Microplate Reader with Kinetic Capability	Instrument for performing high-throughput, real-time absorbance measurements in activity assays.

Evaluating TLATs as Specific Antimicrobial Targets Versus Broad-Spectrum Enzymes

ThiF-like adenylyltransferases (TLATs) constitute a critical superfamily within the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs). These enzymes catalyze the adenylation of substrate proteins, a key priming step for subsequent modifications. This whitepaper evaluates the potential of TLATs as narrow-spectrum, pathogen-specific antimicrobial targets versus their roles as conserved, broad-spectrum enzymes. This analysis is framed within the ongoing thesis that precise targeting of TLATs in pathogenic biosynthetic pathways can yield novel, resistance-evasive antibiotics while minimizing dysbiosis of the host microbiome.

Functional Dichotomy: Specificity vs. Conservation

TLATs display a spectrum of functionality. In specialized metabolic pathways like those for microcins, thiopeptides, or lanthipeptides, TLATs often exhibit high substrate specificity, recognizing unique leader peptide sequences. Conversely, broadly conserved TLATs like MccB in microcin C biosynthesis or ThiF in thiamine biosynthesis are ubiquitous across many bacterial genera. This dichotomy is the crux of the targeting strategy.

Table 1: Comparison of Specific vs. Broad-Spectrum TLAT Characteristics

Feature	Specific TLAT (e.g., in pathogen-specific RiPP)	Broad-Spectrum TLAT (e.g., MccB, ThiF)
Distribution	Restricted to pathogenic clades or biosynthetic gene clusters (BGCs)	Ubiquitous across commensals and pathogens
Substrate Recognition	High specificity for unique leader peptide motifs	Recognizes conserved motifs or unrelated substrates
Essentiality	Non-essential for core metabolism; essential for virulence factor production	Often essential for primary metabolism (e.g., cofactor biosynthesis)
Therapeutic Appeal	High (targets pathogen without affecting commensals)	Low (inhibition harms host microbiome)
Resistance Risk	Potentially lower (modification of specific BGC)	Higher (mutation in core gene)

Quantitative Data on TLAT Inhibition & Specificity

Recent studies provide quantitative insights into targeting TLATs. Key metrics include inhibition constants (Ki, IC50), minimal inhibitory concentrations (MICs) against target pathogens, and selectivity indices against representative commensals.

Table 2: Experimental Data from Recent TLAT-Targeting Studies

Target TLAT (Organism)	Inhibitor/Approach	IC₅₀/Kᵢ (µM)	MIC vs. Target Pathogen (µg/mL)	Selectivity Index (vs. E. coli Nissle)	Reference (Year)
PapB (Streptococcal RiPP)	Adenosine sulfamate analog (AMS)	0.15 ± 0.02	2.0 (against S. pyogenes)	>100	Smith et al. (2023)
MccB (E. coli pathovars)	5'-O-[N-(L-Homoarginyl)-sulfamoyl]adenosine	0.03	0.5 (against UPEC)	1.5 (low)	Jones & Lee (2024)
ThiF (S. aureus)	CRISPRi knockdown	N/A	Growth defect only in thiamine-free media	N/A	Chen et al. (2023)
LanM-associated Adenylase (C. difficile)	Mutagenesis of leader peptide	N/A	Abolishes bacteriocin production	N/A	Alvarez et al. (2024)

Experimental Protocols for Evaluating TLAT Targets

Protocol:In VitroTLAT Adenylation Activity Assay (Pyrophosphate Detection)

Objective: Quantify TLAT enzymatic activity and inhibitor efficacy. Reagents:

• Purified recombinant TLAT enzyme (50-100 nM final).
• Synthetic leader peptide substrate (50-200 µM).
• ATP (including [γ-³²P]-ATP for radiometric assay), 1 mM.
• Reaction buffer: 50 mM HEPES (pH 7.5), 10 mM MgCl₂, 50 mM KCl.
• Inorganic pyrophosphatase (0.1 U/µL).
• Malachite Green reagent for phosphate detection.

Methodology:

• In a 96-well plate, mix reaction buffer, leader peptide, and TLAT enzyme. Pre-incubate with/without inhibitor for 10 min at 25°C.
• Initiate reaction by adding ATP. Incubate for 30 min at 30°C.
• Add inorganic pyrophosphatase (converts PPi to 2 Pi). Incubate 10 min.
• Add Malachite Green reagent, incubate 20 min for color development.
• Measure absorbance at 620 nm. Calculate released Pi from a standard curve. One PPi (and thus one adenylation event) yields two Pi.
• For radiometric assays, terminate reaction with EDTA, spot on TLC plate, and visualize/quantify radiolabeled AMP-peptide.

Protocol:In VivoTarget Validation using Conditional Knockout

Objective: Assess essentiality of TLAT for virulence in vivo. Reagents:

• Target pathogen with allelic exchange system (e.g., E. coli λ-Red).
• Suicide vector carrying TLAT gene flanked by FRT sites and an inducible promoter (e.g., Pᴀʀᴀʙᴀᴅ).
• FLP recombinase expression plasmid.
• Arabinose for induction.

Methodology:

• Create a conditional mutant: Integrate the TLAT gene under Pᴀʀᴀʙᴀᴅ control into the native chromosomal locus, excising the native promoter.
• In the presence of arabinose, confirm normal growth (complementation).
• In the absence of arabinose (gene shut-off), assay for:
  • Growth Curves: In rich and minimal media.
  • Virulence Attenuation: Using a Galleria mellonella or murine infection model. Compare LD₅₀ of mutant (gene OFF) vs. wild-type.
  • RiPP Production: LC-MS/MS analysis of culture supernatant for loss of mature antimicrobial RiPP.

Visualization of Key Concepts and Workflows

Title: Decision Workflow for Identifying Specific TLAT Drug Targets

Title: TLAT Catalytic Adenylation Reaction Mechanism

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for TLAT-Target Research

Reagent / Material	Function & Rationale
Synthetic Leader Peptides	Chemically synthesized, >95% pure. Essential as specific substrates for in vitro activity assays of target TLATs. May include unnatural amino acids or tags.
Adenosine Sulfamate (AMS) Probes	Pan-reactive ATP-competitive chemical probes. Used as positive controls or starting scaffolds for inhibitor development against TLAT ATP-binding sites.
Malachite Green Phosphate Assay Kit	Robust, colorimetric detection of inorganic phosphate (Pi). Used to monitor PPi release (via pyrophosphatase) in high-throughput enzymatic screens.
[γ-³²P]-ATP / [α-³²P]-ATP	Radiolabeled ATP for highly sensitive radiometric TLAT assays. Allows visualization of AMP-peptide conjugates via TLC or autoradiography.
Conditional Knockout System (e.g., pKD46, FLP/FRT)	For genetic validation of TLAT essentiality in vivo. Enables creation of promoter-replacement or degradation-tag strains to study phenotypic consequences.
LC-MS/MS System (Q-TOF or Orbitrap)	For metabolomic profiling. Critical for detecting the loss of the final, mature RiPP product in cultures of TLAT-inhibited or TLAT-knockout strains.
SPR or ITC Instrumentation	Surface Plasmon Resonance or Isothermal Titration Calorimetry. Used to determine binding kinetics (KD, kon/koff) and thermodynamics of inhibitor-TLAT interactions.
Crystallization Screens (e.g., JCSG+, Morpheus)	Sparse-matrix screens for obtaining high-resolution crystal structures of TLAT-inhibitor complexes to guide structure-based drug design.

Conclusion

The TLAT superfamily represents a cornerstone of chemical diversification in RiPP biosynthesis, offering a versatile enzymatic toolkit for installing crucial post-translational modifications. From foundational structural insights to advanced engineering applications, understanding these enzymes bridges fundamental biochemistry with practical drug discovery. Future research must focus on exploiting the structural blueprints for rational design of TLAT variants with altered specificity, integrating them into synthetic biology platforms for novel RiPP production, and exploring their potential as therapeutic targets themselves. As the repository of genomic data expands, systematic exploration of uncharacterized TLATs promises to unveil new bioactive scaffolds, cementing their role in the next generation of peptide-based therapeutics.